{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"103","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"D","per_page":12,"people":[{"id":437104,"version":1,"owner_type":"Person","owner_id":6127,"payload":{"bio":"\u003cp\u003eAnne Dana is a partner in King \u0026amp; Spalding\u0026rsquo;s Global Human Capital \u0026amp; Compliance practice. She is an innovative litigator whose practice focuses on complex employment litigation, defending management against claims of discrimination, harassment, and retaliation under federal, state and city laws. Anne represents employers in state and federal courts in New York, arbitration panels, and federal, state and city agencies. These include the Equal Employment Opportunity Commission, New York State Division of Human Rights, and New York City Human Rights Commission. She also represents clients in disputes involving claims of fraud, breach of contract, breach of fiduciary duty, and whistleblowing. A former commercial litigator, Anne has experience with complex commercial litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAnne counsels clients generally on a wide range of employment issues, including disciplinary actions and terminations, employment and separation agreements, employment policies and practices, internal complaints and investigations of alleged employee misconduct, and litigation avoidance.\u003c/p\u003e\n\u003cp\u003eAnne also extensively advises clients on compliance with harassment and discrimination laws around the country, including on mandatory policies, nondisclosure agreements and confidentiality provisions, training requirements, and other notice and poster requirements. She regularly conducts anti-harassment trainings, conducts investigations in response to internal complaints, and negotiates settlement and separation agreements in accordance with these laws. Anne helps track the development of laws in this area from proposed legislation through enforcement and is a thought leader in the era of #MeToo litigation.\u003c/p\u003e\n\u003cp\u003eAnne represents clients in a diverse range of industries, including banking and finance, telecommunications, entertainment, health care, hospitality, food service, retail, and higher education.\u003c/p\u003e","slug":"anne-dana","email":"adana@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":121,"guid":"121.capabilities","index":0,"source":"capabilities"},{"id":15,"guid":"15.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":5,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":6,"source":"smartTags"},{"id":81,"guid":"81.capabilities","index":7,"source":"capabilities"}],"is_active":true,"last_name":"Dana","nick_name":"Anne","clerkships":[],"first_name":"Anne","title_rank":9999,"updated_by":202,"law_schools":[{"id":613,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAnne Dana is a partner in King \u0026amp; Spalding\u0026rsquo;s Global Human Capital \u0026amp; Compliance practice. She is an innovative litigator whose practice focuses on complex employment litigation, defending management against claims of discrimination, harassment, and retaliation under federal, state and city laws. Anne represents employers in state and federal courts in New York, arbitration panels, and federal, state and city agencies. These include the Equal Employment Opportunity Commission, New York State Division of Human Rights, and New York City Human Rights Commission. She also represents clients in disputes involving claims of fraud, breach of contract, breach of fiduciary duty, and whistleblowing. A former commercial litigator, Anne has experience with complex commercial litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAnne counsels clients generally on a wide range of employment issues, including disciplinary actions and terminations, employment and separation agreements, employment policies and practices, internal complaints and investigations of alleged employee misconduct, and litigation avoidance.\u003c/p\u003e\n\u003cp\u003eAnne also extensively advises clients on compliance with harassment and discrimination laws around the country, including on mandatory policies, nondisclosure agreements and confidentiality provisions, training requirements, and other notice and poster requirements. She regularly conducts anti-harassment trainings, conducts investigations in response to internal complaints, and negotiates settlement and separation agreements in accordance with these laws. Anne helps track the development of laws in this area from proposed legislation through enforcement and is a thought leader in the era of #MeToo litigation.\u003c/p\u003e\n\u003cp\u003eAnne represents clients in a diverse range of industries, including banking and finance, telecommunications, entertainment, health care, hospitality, food service, retail, and higher education.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9156}]},"capability_group_id":2},"created_at":"2025-09-11T13:44:55.000Z","updated_at":"2025-09-11T13:44:55.000Z","searchable_text":"Dana{{ FIELD }}Anne Dana is a partner in King \u0026amp; Spalding’s Global Human Capital \u0026amp; Compliance practice. She is an innovative litigator whose practice focuses on complex employment litigation, defending management against claims of discrimination, harassment, and retaliation under federal, state and city laws. Anne represents employers in state and federal courts in New York, arbitration panels, and federal, state and city agencies. These include the Equal Employment Opportunity Commission, New York State Division of Human Rights, and New York City Human Rights Commission. She also represents clients in disputes involving claims of fraud, breach of contract, breach of fiduciary duty, and whistleblowing. A former commercial litigator, Anne has experience with complex commercial litigation.\nAnne counsels clients generally on a wide range of employment issues, including disciplinary actions and terminations, employment and separation agreements, employment policies and practices, internal complaints and investigations of alleged employee misconduct, and litigation avoidance.\nAnne also extensively advises clients on compliance with harassment and discrimination laws around the country, including on mandatory policies, nondisclosure agreements and confidentiality provisions, training requirements, and other notice and poster requirements. She regularly conducts anti-harassment trainings, conducts investigations in response to internal complaints, and negotiates settlement and separation agreements in accordance with these laws. Anne helps track the development of laws in this area from proposed legislation through enforcement and is a thought leader in the era of #MeToo litigation.\nAnne represents clients in a diverse range of industries, including banking and finance, telecommunications, entertainment, health care, hospitality, food service, retail, and higher education. Partner New York University New York University School of Law Duke University Duke University School of Law Duke University Duke University School of Law New York","searchable_name":"Anne R. Dana","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442361,"version":1,"owner_type":"Person","owner_id":853,"payload":{"bio":"\u003cp\u003eTodd Davis is a partner with King \u0026amp; Spalding's Trial \u0026amp; Global Disputes practice group. For the last twenty-eight years, Mr. Davis' practice has been devoted to trying high-stakes products liability cases, including those involving medications, medical devices and consumer products.\u0026nbsp; His involvement includes cross-examining plaintiffs\u0026rsquo; key causation and medical expert witnesses at trial and in deposition. \u0026nbsp;Mr. Davis\u0026rsquo; practice\u0026nbsp;involves representing pharmaceutical and medical device companies, as well as other product manufacturers, in mass tort, consumer fraud and class action litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMr. Davis has been recognized in Legal 500\u0026rsquo;s Product Liability and Mass Tort Defense in the Pharma and Medical Device category.\u003c/p\u003e","slug":"todd-davis","email":"tdavis@kslaw.com","phone":null,"matters":["\u003cp\u003eTrying three cases for\u0026nbsp;\u003cstrong\u003eGlaxoSmithKline\u003c/strong\u003e\u0026nbsp;in the Philadelphia Court of Common Pleas, Pennsylvania, alleging that Paxil causes birth defects (2016, 2010, 2009). In two trials, the courts dismissed plaintiffs' claims because plaintiffs could not prove proximate causation. In the third, which was plaintiffs' No. 1 pick for trial, plaintiffs were awarded compensatory damages less than the actual medical expenses incurred and no punitive damages.\u003c/p\u003e","\u003cp\u003eTrying the first \u0026ldquo;innovator liability\u0026rdquo; prescription drug case to go to trial (\u003cem\u003eDolin v. GSK,\u0026nbsp;\u003c/em\u003e2017\u003cem\u003e).\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eTrying cases for R.J. Reynolds Tobacco Company as part of the\u0026nbsp;\u003cem\u003eEngle\u003c/em\u003e-progeny litigation in Florida (2013, 2014, 2018, 2019 and 2020).\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003emedical device and pharmaceutical companies\u003c/strong\u003e\u0026nbsp;in federal multi-district litigation and state consolidated proceedings. Defeating efforts to certify a\u0026nbsp;\u003cstrong\u003enationwide class\u003c/strong\u003e\u0026nbsp;of Paxil users under personal injury and consumer fraud theories.\u0026nbsp;\u003cem\u003eIn re Paxil,\u003c/em\u003e\u0026nbsp;212 F.R.D. 539 (C.D. Cal. 2003). This decision has been referred to as one of the \u0026ldquo;Big Four\u0026rdquo; federal court rulings denying class certification in pharmaceutical cases.\u0026nbsp;\u003cem\u003eSee\u003c/em\u003e\u0026nbsp;\u003cem\u003eIn\u003c/em\u003e\u0026nbsp;\u003cem\u003ere\u003c/em\u003e\u0026nbsp;\u003cem\u003ePrempro\u003c/em\u003e\u0026nbsp;\u003cem\u003eProds. Liab. Lit.\u003c/em\u003e, 230 F.R.D. 555 (E.D. Ark. 2005).\u003c/p\u003e","\u003cp\u003eDefeating efforts to certify\u0026nbsp;\u003cstrong\u003ea statewide claim\u003c/strong\u003e\u0026nbsp;of Paxil users under California\u0026rsquo;s Unfair Competition Law, \u0026sect; 17200\u003cem\u003e.\u003c/em\u003e\u0026nbsp;\u003cem\u003eIn re Paxil,\u003c/em\u003e\u0026nbsp;218 F.R.D. 242 (C.D. Cal. 2003).\u003c/p\u003e","\u003cp\u003eDefeating efforts to certify a\u0026nbsp;\u003cstrong\u003enationwide class\u003c/strong\u003e\u0026nbsp;of pediatric patients who were prescribed a medication not approved by the FDA to treat patients under 18.\u0026nbsp;\u003cem\u003ePamela Blain, et al. v. SmithKline Beecham Corp\u003c/em\u003e., 240 F.R.D. 179 (E.D. Pa. 2007).\u003c/p\u003e","\u003cp\u003eObtaining summary judgments based on federal preemption of state law\u0026nbsp;\u003cstrong\u003efailure-to-warn claims\u003c/strong\u003e\u0026nbsp;in cases involving a prescription medication.\u0026nbsp;\u003cem\u003eE.g., O\u0026rsquo;Neal v. SmithKline Beecham Corp.\u003c/em\u003e, 551 F.Supp.2d 993 (E.D. Cal. 2008);\u0026nbsp;\u003cem\u003eCandace Miller et al v. SmithKline Beecham Corporation, d/b/a GlaxoSmithKline\u003c/em\u003e, slip op., 2008 WL 510449 (N.D. Okla).\u003c/p\u003e","\u003cp\u003eSuccessfully excluding plaintiff\u0026rsquo;s experts\u0026rsquo; opinions that breast implants cause systemic illness on\u0026nbsp;\u003cstrong\u003e\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;grounds\u003c/strong\u003e\u0026nbsp;in the first breast implant case set for trial in Georgia. Mr. Davis successfully defended that decision on appeal in the first federal appellate decision in the country addressing\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;issues in the breast implant litigation.\u0026nbsp;\u003cem\u003eAllison v. McGhan Medical Corp.\u003c/em\u003e\u0026nbsp;184 F.3d 1300 (11th Cir. 1999).\u003c/p\u003e","\u003cp\u003eSuccessfully defending\u0026nbsp;\u003cstrong\u003ea product liability lawsuit\u003c/strong\u003e\u0026nbsp;filed in the \u0026ldquo;rocket-docket\u0026rdquo; of the U.S.D.C., Eastern District of Virginia that involved allegations that a uniformed officer of the Secret Service committed murder and then suicide because of a prescription medication. After an intensive 2-1/2 month discovery period, plaintiff dismissed his lawsuit on the eve of trial. The defendant paid nothing in settlement.\u003c/p\u003e","\u003cp\u003eSuccessfully defending on appeal summary judgment for\u0026nbsp;\u003cstrong\u003ea pharmaceutical manufacturer\u003c/strong\u003e\u0026nbsp;based upon the learned intermediary doctrine.\u0026nbsp;\u003cem\u003eAllgood v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline\u003c/em\u003e, No. 06-cv-3506, 2008 WL 483574 (E.D. La. Feb. 20, 2008),\u0026nbsp;\u003cem\u003eaff\u0026rsquo;d by\u003c/em\u003e\u0026nbsp;No. 08- 30329, 2009 WL 646285 (5th Cir. Mar. 13, 2009),\u0026nbsp;\u003cem\u003ereh\u0026rsquo;g denied by\u003c/em\u003e\u0026nbsp;No. 08-30329 (5th Cir. May 6, 2009).\u003c/p\u003e","\u003cp\u003eObtaining summary judgment in\u0026nbsp;\u003cstrong\u003ea product liability lawsuit\u003c/strong\u003e\u0026nbsp;involving a prescription medication within four months after plaintiff filed his lawsuit,\u0026nbsp;\u003cem\u003eHoward v. GlaxoSmithKline\u003c/em\u003e, Case No. 05-1525 (U.S.D.C., E.D. Cal.)\u0026nbsp;\u003cem\u003eaff\u0026rsquo;d\u003c/em\u003e\u0026nbsp;(9th Cir. 2007), and obtaining summary judgments in two product liability wrongful death lawsuits when plaintiffs\u0026rsquo; claimed they did not timely file their lawsuit because of the defendant\u0026rsquo;s \u0026ldquo;fraudulent concealment.\u0026rdquo;\u0026nbsp;\u003cem\u003ePamela Blain, et al., v. SmithKline Beecham Corporation d/b/a GlaxoSmithKline\u003c/em\u003e, Civil Action No. 07-1157- MLB-DWB (U.S.D.C., D. Kan.);\u0026nbsp;\u003cem\u003eCollins v. SmithKlineBeecham Corp.,\u003c/em\u003e\u0026nbsp;Philadelphia Court of Common Pleas, Pennsylvania,\u0026nbsp;\u003cem\u003eaff'd\u003c/em\u003e\u0026nbsp;on appeal.\u003c/p\u003e","\u003cp\u003eManaging massive electronic discovery and hard copy productions and coordinating discovery of plaintiffs\u0026rsquo; claims.\u003c/p\u003e","\u003cp\u003eSuccessfully defending against motions to compel that sought thousands of privileged documents in\u0026nbsp;\u003cstrong\u003epersonal injury lawsuits\u003c/strong\u003e\u0026nbsp;involving prescription medications.\u003c/p\u003e","\u003cp\u003eMajor responsibility in\u0026nbsp;\u003cstrong\u003eseveral hundred breast implant cases\u003c/strong\u003e\u0026nbsp;in Georgia, Florida, Alabama, Mississippi, Tennessee, South Carolina, North Carolina, Virginia and the District of Columbia. Mr. Davis second-chaired the trial of the first breast implant case tried in Tennessee. The trial lasted five-and-a-half weeks and included claims of both local and systemic injury. The jury returned a defense verdict.\u003c/p\u003e","\u003cp\u003eSuccessfully arguing for\u0026nbsp;\u003cstrong\u003etransfer of a host of cases\u003c/strong\u003e\u0026nbsp;to the plaintiffs\u0026rsquo; home states under 28 U.S.C. \u0026sect; 1404. (Plaintiffs attempted to bring their lawsuits in the state of the pharmaceutical company\u0026rsquo;s business office as opposed to the states of their residence.)\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003ehigh-ranking company executives\u003c/strong\u003e\u0026nbsp;in depositions.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ea manufacturer\u003c/strong\u003e\u0026nbsp;in an emergency appeal of an order allowing plaintiffs to depose the manufacturer\u0026rsquo;s in-house litigation counsel. In an appeal to the Kentucky Supreme Court, Mr. Davis successfully argued for reversal of the trial court\u0026rsquo;s order.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":63}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":2,"source":"smartTags"},{"id":764,"guid":"764.smart_tags","index":3,"source":"smartTags"},{"id":3,"guid":"3.capabilities","index":4,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":5,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":8,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Davis","nick_name":"Todd","clerkships":[],"first_name":"Todd","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"P.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eTodd Davis is a partner with King \u0026amp; Spalding's Trial \u0026amp; Global Disputes practice group. For the last twenty-eight years, Mr. Davis' practice has been devoted to trying high-stakes products liability cases, including those involving medications, medical devices and consumer products.\u0026nbsp; His involvement includes cross-examining plaintiffs\u0026rsquo; key causation and medical expert witnesses at trial and in deposition. \u0026nbsp;Mr. Davis\u0026rsquo; practice\u0026nbsp;involves representing pharmaceutical and medical device companies, as well as other product manufacturers, in mass tort, consumer fraud and class action litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMr. Davis has been recognized in Legal 500\u0026rsquo;s Product Liability and Mass Tort Defense in the Pharma and Medical Device category.\u003c/p\u003e","matters":["\u003cp\u003eTrying three cases for\u0026nbsp;\u003cstrong\u003eGlaxoSmithKline\u003c/strong\u003e\u0026nbsp;in the Philadelphia Court of Common Pleas, Pennsylvania, alleging that Paxil causes birth defects (2016, 2010, 2009). In two trials, the courts dismissed plaintiffs' claims because plaintiffs could not prove proximate causation. In the third, which was plaintiffs' No. 1 pick for trial, plaintiffs were awarded compensatory damages less than the actual medical expenses incurred and no punitive damages.\u003c/p\u003e","\u003cp\u003eTrying the first \u0026ldquo;innovator liability\u0026rdquo; prescription drug case to go to trial (\u003cem\u003eDolin v. GSK,\u0026nbsp;\u003c/em\u003e2017\u003cem\u003e).\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eTrying cases for R.J. Reynolds Tobacco Company as part of the\u0026nbsp;\u003cem\u003eEngle\u003c/em\u003e-progeny litigation in Florida (2013, 2014, 2018, 2019 and 2020).\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003emedical device and pharmaceutical companies\u003c/strong\u003e\u0026nbsp;in federal multi-district litigation and state consolidated proceedings. Defeating efforts to certify a\u0026nbsp;\u003cstrong\u003enationwide class\u003c/strong\u003e\u0026nbsp;of Paxil users under personal injury and consumer fraud theories.\u0026nbsp;\u003cem\u003eIn re Paxil,\u003c/em\u003e\u0026nbsp;212 F.R.D. 539 (C.D. Cal. 2003). This decision has been referred to as one of the \u0026ldquo;Big Four\u0026rdquo; federal court rulings denying class certification in pharmaceutical cases.\u0026nbsp;\u003cem\u003eSee\u003c/em\u003e\u0026nbsp;\u003cem\u003eIn\u003c/em\u003e\u0026nbsp;\u003cem\u003ere\u003c/em\u003e\u0026nbsp;\u003cem\u003ePrempro\u003c/em\u003e\u0026nbsp;\u003cem\u003eProds. Liab. Lit.\u003c/em\u003e, 230 F.R.D. 555 (E.D. Ark. 2005).\u003c/p\u003e","\u003cp\u003eDefeating efforts to certify\u0026nbsp;\u003cstrong\u003ea statewide claim\u003c/strong\u003e\u0026nbsp;of Paxil users under California\u0026rsquo;s Unfair Competition Law, \u0026sect; 17200\u003cem\u003e.\u003c/em\u003e\u0026nbsp;\u003cem\u003eIn re Paxil,\u003c/em\u003e\u0026nbsp;218 F.R.D. 242 (C.D. Cal. 2003).\u003c/p\u003e","\u003cp\u003eDefeating efforts to certify a\u0026nbsp;\u003cstrong\u003enationwide class\u003c/strong\u003e\u0026nbsp;of pediatric patients who were prescribed a medication not approved by the FDA to treat patients under 18.\u0026nbsp;\u003cem\u003ePamela Blain, et al. v. SmithKline Beecham Corp\u003c/em\u003e., 240 F.R.D. 179 (E.D. Pa. 2007).\u003c/p\u003e","\u003cp\u003eObtaining summary judgments based on federal preemption of state law\u0026nbsp;\u003cstrong\u003efailure-to-warn claims\u003c/strong\u003e\u0026nbsp;in cases involving a prescription medication.\u0026nbsp;\u003cem\u003eE.g., O\u0026rsquo;Neal v. SmithKline Beecham Corp.\u003c/em\u003e, 551 F.Supp.2d 993 (E.D. Cal. 2008);\u0026nbsp;\u003cem\u003eCandace Miller et al v. SmithKline Beecham Corporation, d/b/a GlaxoSmithKline\u003c/em\u003e, slip op., 2008 WL 510449 (N.D. Okla).\u003c/p\u003e","\u003cp\u003eSuccessfully excluding plaintiff\u0026rsquo;s experts\u0026rsquo; opinions that breast implants cause systemic illness on\u0026nbsp;\u003cstrong\u003e\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;grounds\u003c/strong\u003e\u0026nbsp;in the first breast implant case set for trial in Georgia. Mr. Davis successfully defended that decision on appeal in the first federal appellate decision in the country addressing\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;issues in the breast implant litigation.\u0026nbsp;\u003cem\u003eAllison v. McGhan Medical Corp.\u003c/em\u003e\u0026nbsp;184 F.3d 1300 (11th Cir. 1999).\u003c/p\u003e","\u003cp\u003eSuccessfully defending\u0026nbsp;\u003cstrong\u003ea product liability lawsuit\u003c/strong\u003e\u0026nbsp;filed in the \u0026ldquo;rocket-docket\u0026rdquo; of the U.S.D.C., Eastern District of Virginia that involved allegations that a uniformed officer of the Secret Service committed murder and then suicide because of a prescription medication. After an intensive 2-1/2 month discovery period, plaintiff dismissed his lawsuit on the eve of trial. The defendant paid nothing in settlement.\u003c/p\u003e","\u003cp\u003eSuccessfully defending on appeal summary judgment for\u0026nbsp;\u003cstrong\u003ea pharmaceutical manufacturer\u003c/strong\u003e\u0026nbsp;based upon the learned intermediary doctrine.\u0026nbsp;\u003cem\u003eAllgood v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline\u003c/em\u003e, No. 06-cv-3506, 2008 WL 483574 (E.D. La. Feb. 20, 2008),\u0026nbsp;\u003cem\u003eaff\u0026rsquo;d by\u003c/em\u003e\u0026nbsp;No. 08- 30329, 2009 WL 646285 (5th Cir. Mar. 13, 2009),\u0026nbsp;\u003cem\u003ereh\u0026rsquo;g denied by\u003c/em\u003e\u0026nbsp;No. 08-30329 (5th Cir. May 6, 2009).\u003c/p\u003e","\u003cp\u003eObtaining summary judgment in\u0026nbsp;\u003cstrong\u003ea product liability lawsuit\u003c/strong\u003e\u0026nbsp;involving a prescription medication within four months after plaintiff filed his lawsuit,\u0026nbsp;\u003cem\u003eHoward v. GlaxoSmithKline\u003c/em\u003e, Case No. 05-1525 (U.S.D.C., E.D. Cal.)\u0026nbsp;\u003cem\u003eaff\u0026rsquo;d\u003c/em\u003e\u0026nbsp;(9th Cir. 2007), and obtaining summary judgments in two product liability wrongful death lawsuits when plaintiffs\u0026rsquo; claimed they did not timely file their lawsuit because of the defendant\u0026rsquo;s \u0026ldquo;fraudulent concealment.\u0026rdquo;\u0026nbsp;\u003cem\u003ePamela Blain, et al., v. SmithKline Beecham Corporation d/b/a GlaxoSmithKline\u003c/em\u003e, Civil Action No. 07-1157- MLB-DWB (U.S.D.C., D. Kan.);\u0026nbsp;\u003cem\u003eCollins v. SmithKlineBeecham Corp.,\u003c/em\u003e\u0026nbsp;Philadelphia Court of Common Pleas, Pennsylvania,\u0026nbsp;\u003cem\u003eaff'd\u003c/em\u003e\u0026nbsp;on appeal.\u003c/p\u003e","\u003cp\u003eManaging massive electronic discovery and hard copy productions and coordinating discovery of plaintiffs\u0026rsquo; claims.\u003c/p\u003e","\u003cp\u003eSuccessfully defending against motions to compel that sought thousands of privileged documents in\u0026nbsp;\u003cstrong\u003epersonal injury lawsuits\u003c/strong\u003e\u0026nbsp;involving prescription medications.\u003c/p\u003e","\u003cp\u003eMajor responsibility in\u0026nbsp;\u003cstrong\u003eseveral hundred breast implant cases\u003c/strong\u003e\u0026nbsp;in Georgia, Florida, Alabama, Mississippi, Tennessee, South Carolina, North Carolina, Virginia and the District of Columbia. Mr. Davis second-chaired the trial of the first breast implant case tried in Tennessee. The trial lasted five-and-a-half weeks and included claims of both local and systemic injury. The jury returned a defense verdict.\u003c/p\u003e","\u003cp\u003eSuccessfully arguing for\u0026nbsp;\u003cstrong\u003etransfer of a host of cases\u003c/strong\u003e\u0026nbsp;to the plaintiffs\u0026rsquo; home states under 28 U.S.C. \u0026sect; 1404. (Plaintiffs attempted to bring their lawsuits in the state of the pharmaceutical company\u0026rsquo;s business office as opposed to the states of their residence.)\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003ehigh-ranking company executives\u003c/strong\u003e\u0026nbsp;in depositions.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ea manufacturer\u003c/strong\u003e\u0026nbsp;in an emergency appeal of an order allowing plaintiffs to depose the manufacturer\u0026rsquo;s in-house litigation counsel. In an appeal to the Kentucky Supreme Court, Mr. Davis successfully argued for reversal of the trial court\u0026rsquo;s order.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":805}]},"capability_group_id":3},"created_at":"2025-11-05T05:03:30.000Z","updated_at":"2025-11-05T05:03:30.000Z","searchable_text":"Davis{{ FIELD }}Trying three cases for GlaxoSmithKline in the Philadelphia Court of Common Pleas, Pennsylvania, alleging that Paxil causes birth defects (2016, 2010, 2009). In two trials, the courts dismissed plaintiffs' claims because plaintiffs could not prove proximate causation. In the third, which was plaintiffs' No. 1 pick for trial, plaintiffs were awarded compensatory damages less than the actual medical expenses incurred and no punitive damages.{{ FIELD }}Trying the first “innovator liability” prescription drug case to go to trial (Dolin v. GSK, 2017).{{ FIELD }}Trying cases for R.J. Reynolds Tobacco Company as part of the Engle-progeny litigation in Florida (2013, 2014, 2018, 2019 and 2020).{{ FIELD }}Representing medical device and pharmaceutical companies in federal multi-district litigation and state consolidated proceedings. Defeating efforts to certify a nationwide class of Paxil users under personal injury and consumer fraud theories. In re Paxil, 212 F.R.D. 539 (C.D. Cal. 2003). This decision has been referred to as one of the “Big Four” federal court rulings denying class certification in pharmaceutical cases. See In re Prempro Prods. Liab. Lit., 230 F.R.D. 555 (E.D. Ark. 2005).{{ FIELD }}Defeating efforts to certify a statewide claim of Paxil users under California’s Unfair Competition Law, § 17200. In re Paxil, 218 F.R.D. 242 (C.D. Cal. 2003).{{ FIELD }}Defeating efforts to certify a nationwide class of pediatric patients who were prescribed a medication not approved by the FDA to treat patients under 18. Pamela Blain, et al. v. SmithKline Beecham Corp., 240 F.R.D. 179 (E.D. Pa. 2007).{{ FIELD }}Obtaining summary judgments based on federal preemption of state law failure-to-warn claims in cases involving a prescription medication. E.g., O’Neal v. SmithKline Beecham Corp., 551 F.Supp.2d 993 (E.D. Cal. 2008); Candace Miller et al v. SmithKline Beecham Corporation, d/b/a GlaxoSmithKline, slip op., 2008 WL 510449 (N.D. Okla).{{ FIELD }}Successfully excluding plaintiff’s experts’ opinions that breast implants cause systemic illness on Daubert grounds in the first breast implant case set for trial in Georgia. Mr. Davis successfully defended that decision on appeal in the first federal appellate decision in the country addressing Daubert issues in the breast implant litigation. Allison v. McGhan Medical Corp. 184 F.3d 1300 (11th Cir. 1999).{{ FIELD }}Successfully defending a product liability lawsuit filed in the “rocket-docket” of the U.S.D.C., Eastern District of Virginia that involved allegations that a uniformed officer of the Secret Service committed murder and then suicide because of a prescription medication. After an intensive 2-1/2 month discovery period, plaintiff dismissed his lawsuit on the eve of trial. The defendant paid nothing in settlement.{{ FIELD }}Successfully defending on appeal summary judgment for a pharmaceutical manufacturer based upon the learned intermediary doctrine. Allgood v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline, No. 06-cv-3506, 2008 WL 483574 (E.D. La. Feb. 20, 2008), aff’d by No. 08- 30329, 2009 WL 646285 (5th Cir. Mar. 13, 2009), reh’g denied by No. 08-30329 (5th Cir. May 6, 2009).{{ FIELD }}Obtaining summary judgment in a product liability lawsuit involving a prescription medication within four months after plaintiff filed his lawsuit, Howard v. GlaxoSmithKline, Case No. 05-1525 (U.S.D.C., E.D. Cal.) aff’d (9th Cir. 2007), and obtaining summary judgments in two product liability wrongful death lawsuits when plaintiffs’ claimed they did not timely file their lawsuit because of the defendant’s “fraudulent concealment.” Pamela Blain, et al., v. SmithKline Beecham Corporation d/b/a GlaxoSmithKline, Civil Action No. 07-1157- MLB-DWB (U.S.D.C., D. Kan.); Collins v. SmithKlineBeecham Corp., Philadelphia Court of Common Pleas, Pennsylvania, aff'd on appeal.{{ FIELD }}Managing massive electronic discovery and hard copy productions and coordinating discovery of plaintiffs’ claims.{{ FIELD }}Successfully defending against motions to compel that sought thousands of privileged documents in personal injury lawsuits involving prescription medications.{{ FIELD }}Major responsibility in several hundred breast implant cases in Georgia, Florida, Alabama, Mississippi, Tennessee, South Carolina, North Carolina, Virginia and the District of Columbia. Mr. Davis second-chaired the trial of the first breast implant case tried in Tennessee. The trial lasted five-and-a-half weeks and included claims of both local and systemic injury. The jury returned a defense verdict.{{ FIELD }}Successfully arguing for transfer of a host of cases to the plaintiffs’ home states under 28 U.S.C. § 1404. (Plaintiffs attempted to bring their lawsuits in the state of the pharmaceutical company’s business office as opposed to the states of their residence.){{ FIELD }}Defending high-ranking company executives in depositions.{{ FIELD }}Representing a manufacturer in an emergency appeal of an order allowing plaintiffs to depose the manufacturer’s in-house litigation counsel. In an appeal to the Kentucky Supreme Court, Mr. Davis successfully argued for reversal of the trial court’s order.{{ FIELD }}Todd Davis is a partner with King \u0026amp; Spalding's Trial \u0026amp; Global Disputes practice group. For the last twenty-eight years, Mr. Davis' practice has been devoted to trying high-stakes products liability cases, including those involving medications, medical devices and consumer products.  His involvement includes cross-examining plaintiffs’ key causation and medical expert witnesses at trial and in deposition.  Mr. Davis’ practice involves representing pharmaceutical and medical device companies, as well as other product manufacturers, in mass tort, consumer fraud and class action litigation.\nMr. Davis has been recognized in Legal 500’s Product Liability and Mass Tort Defense in the Pharma and Medical Device category. Todd P Davis Partner Stetson University Stetson University College of Law Mercer University Mercer University Walter F. George School of Law U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Tenth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Middle District of Florida U.S. District Court for the Middle District of Georgia U.S. District Court for the Northern District of Georgia U.S. District Court for the Southern District of Georgia Florida Georgia American Bar Association State Bar of Georgia Atlanta Bar Association The Florida Bar Sixth and Eleventh Circuit Court of Appeals Trying three cases for GlaxoSmithKline in the Philadelphia Court of Common Pleas, Pennsylvania, alleging that Paxil causes birth defects (2016, 2010, 2009). In two trials, the courts dismissed plaintiffs' claims because plaintiffs could not prove proximate causation. In the third, which was plaintiffs' No. 1 pick for trial, plaintiffs were awarded compensatory damages less than the actual medical expenses incurred and no punitive damages. Trying the first “innovator liability” prescription drug case to go to trial (Dolin v. GSK, 2017). Trying cases for R.J. Reynolds Tobacco Company as part of the Engle-progeny litigation in Florida (2013, 2014, 2018, 2019 and 2020). Representing medical device and pharmaceutical companies in federal multi-district litigation and state consolidated proceedings. Defeating efforts to certify a nationwide class of Paxil users under personal injury and consumer fraud theories. In re Paxil, 212 F.R.D. 539 (C.D. Cal. 2003). This decision has been referred to as one of the “Big Four” federal court rulings denying class certification in pharmaceutical cases. See In re Prempro Prods. Liab. Lit., 230 F.R.D. 555 (E.D. Ark. 2005). Defeating efforts to certify a statewide claim of Paxil users under California’s Unfair Competition Law, § 17200. In re Paxil, 218 F.R.D. 242 (C.D. Cal. 2003). Defeating efforts to certify a nationwide class of pediatric patients who were prescribed a medication not approved by the FDA to treat patients under 18. Pamela Blain, et al. v. SmithKline Beecham Corp., 240 F.R.D. 179 (E.D. Pa. 2007). Obtaining summary judgments based on federal preemption of state law failure-to-warn claims in cases involving a prescription medication. E.g., O’Neal v. SmithKline Beecham Corp., 551 F.Supp.2d 993 (E.D. Cal. 2008); Candace Miller et al v. SmithKline Beecham Corporation, d/b/a GlaxoSmithKline, slip op., 2008 WL 510449 (N.D. Okla). Successfully excluding plaintiff’s experts’ opinions that breast implants cause systemic illness on Daubert grounds in the first breast implant case set for trial in Georgia. Mr. Davis successfully defended that decision on appeal in the first federal appellate decision in the country addressing Daubert issues in the breast implant litigation. Allison v. McGhan Medical Corp. 184 F.3d 1300 (11th Cir. 1999). Successfully defending a product liability lawsuit filed in the “rocket-docket” of the U.S.D.C., Eastern District of Virginia that involved allegations that a uniformed officer of the Secret Service committed murder and then suicide because of a prescription medication. After an intensive 2-1/2 month discovery period, plaintiff dismissed his lawsuit on the eve of trial. The defendant paid nothing in settlement. Successfully defending on appeal summary judgment for a pharmaceutical manufacturer based upon the learned intermediary doctrine. Allgood v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline, No. 06-cv-3506, 2008 WL 483574 (E.D. La. Feb. 20, 2008), aff’d by No. 08- 30329, 2009 WL 646285 (5th Cir. Mar. 13, 2009), reh’g denied by No. 08-30329 (5th Cir. May 6, 2009). Obtaining summary judgment in a product liability lawsuit involving a prescription medication within four months after plaintiff filed his lawsuit, Howard v. GlaxoSmithKline, Case No. 05-1525 (U.S.D.C., E.D. Cal.) aff’d (9th Cir. 2007), and obtaining summary judgments in two product liability wrongful death lawsuits when plaintiffs’ claimed they did not timely file their lawsuit because of the defendant’s “fraudulent concealment.” Pamela Blain, et al., v. SmithKline Beecham Corporation d/b/a GlaxoSmithKline, Civil Action No. 07-1157- MLB-DWB (U.S.D.C., D. Kan.); Collins v. SmithKlineBeecham Corp., Philadelphia Court of Common Pleas, Pennsylvania, aff'd on appeal. Managing massive electronic discovery and hard copy productions and coordinating discovery of plaintiffs’ claims. Successfully defending against motions to compel that sought thousands of privileged documents in personal injury lawsuits involving prescription medications. Major responsibility in several hundred breast implant cases in Georgia, Florida, Alabama, Mississippi, Tennessee, South Carolina, North Carolina, Virginia and the District of Columbia. Mr. Davis second-chaired the trial of the first breast implant case tried in Tennessee. The trial lasted five-and-a-half weeks and included claims of both local and systemic injury. The jury returned a defense verdict. Successfully arguing for transfer of a host of cases to the plaintiffs’ home states under 28 U.S.C. § 1404. (Plaintiffs attempted to bring their lawsuits in the state of the pharmaceutical company’s business office as opposed to the states of their residence.) Defending high-ranking company executives in depositions. Representing a manufacturer in an emergency appeal of an order allowing plaintiffs to depose the manufacturer’s in-house litigation counsel. In an appeal to the Kentucky Supreme Court, Mr. Davis successfully argued for reversal of the trial court’s order.","searchable_name":"Todd P. Davis","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":431252,"version":1,"owner_type":"Person","owner_id":3550,"payload":{"bio":"\u003cp\u003eMr. Dawson focuses on complex commercial litigation, including matters involving contract and technology licensing disputes, misappropriation of trade secrets, fraud, and related commercial torts.\u0026nbsp; He has substantial experience defending class actions and multi-plaintiff mass actions.\u0026nbsp; Mr. Dawson represents both early-stage ventures and Fortune 500 companies in the healthcare, pharmaceutical, biotechnology, and medical-device industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Mr. Dawson served as law clerk to the Honorable John T. Copenhaver, Jr. in the U.S. District Court for the Southern District of West Virginia.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe Intractable Obscenity Problem 2.0: The Emerging Circuit Split as to the Constitutionality of \"Local Community Standards\" Online, 60 Cath. U. L. Rev. 719 (2011).\u003c/li\u003e\n\u003c/ul\u003e","slug":"matthew-dawson","email":"mdawson@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":5,"guid":"5.capabilities","index":0,"source":"capabilities"},{"id":15,"guid":"15.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"}],"is_active":true,"last_name":"Dawson","nick_name":"Matthew","clerkships":[{"name":"Judicial Clerk, The Honorable John T. Copenhaver, Jr., U.S. District Court for the Southern District of West Virginia","years_held":"2012-2013"},{"name":"Intern, The Honorable Ricardo M. Urbina, U.S. District Court for the District of Columbia","years_held":"2011"}],"first_name":"Matthew","title_rank":9999,"updated_by":101,"law_schools":[{"id":350,"meta":{"degree":"J.D.","honors":"magna cum laude","is_law_school":1,"graduation_date":"2012-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"H.","name_suffix":"","recognitions":[{"title":"Editor in Chief, Volume 61","detail":"Catholic University Law Review"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMr. Dawson focuses on complex commercial litigation, including matters involving contract and technology licensing disputes, misappropriation of trade secrets, fraud, and related commercial torts.\u0026nbsp; He has substantial experience defending class actions and multi-plaintiff mass actions.\u0026nbsp; Mr. Dawson represents both early-stage ventures and Fortune 500 companies in the healthcare, pharmaceutical, biotechnology, and medical-device industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Mr. Dawson served as law clerk to the Honorable John T. Copenhaver, Jr. in the U.S. District Court for the Southern District of West Virginia.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe Intractable Obscenity Problem 2.0: The Emerging Circuit Split as to the Constitutionality of \"Local Community Standards\" Online, 60 Cath. U. L. Rev. 719 (2011).\u003c/li\u003e\n\u003c/ul\u003e","recognitions":[{"title":"Editor in Chief, Volume 61","detail":"Catholic University Law Review"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10342}]},"capability_group_id":3},"created_at":"2025-07-03T04:53:44.000Z","updated_at":"2025-07-03T04:53:44.000Z","searchable_text":"Dawson{{ FIELD }}{:title=\u0026gt;\"Editor in Chief, Volume 61\", :detail=\u0026gt;\"Catholic University Law Review\"}{{ FIELD }}Mr. Dawson focuses on complex commercial litigation, including matters involving contract and technology licensing disputes, misappropriation of trade secrets, fraud, and related commercial torts.  He has substantial experience defending class actions and multi-plaintiff mass actions.  Mr. Dawson represents both early-stage ventures and Fortune 500 companies in the healthcare, pharmaceutical, biotechnology, and medical-device industries.\nPrior to joining King \u0026amp; Spalding, Mr. Dawson served as law clerk to the Honorable John T. Copenhaver, Jr. in the U.S. District Court for the Southern District of West Virginia.\nPublications\n\nThe Intractable Obscenity Problem 2.0: The Emerging Circuit Split as to the Constitutionality of \"Local Community Standards\" Online, 60 Cath. U. L. Rev. 719 (2011).\n Partner Editor in Chief, Volume 61 Catholic University Law Review Davidson College  Catholic University of America Columbus School of Law U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California Maryland Judicial Clerk, The Honorable John T. Copenhaver, Jr., U.S. District Court for the Southern District of West Virginia Intern, The Honorable Ricardo M. Urbina, U.S. District Court for the District of Columbia","searchable_name":"Matthew H. Dawson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":444001,"version":1,"owner_type":"Person","owner_id":7205,"payload":{"bio":"\u003cp\u003eRob DeConti is a partner in King \u0026amp; Spalding\u0026rsquo;s healthcare practice, specializing in government healthcare fraud investigations, compliance, diligence, the False Claims Act, the Anti-Kickback Statute (AKS), and regulatory compliance and enforcement issues in relation to healthcare transactions. Rob is an expert on all aspects of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) administrative remedies and initiatives, including mandatory and permissive exclusion authorities, the Civil Monetary Penalties Law, the Emergency Medical Treatment and Labor Act (EMTALA), corporate integrity agreements, Select Agent investigations, drug price reporting cases, and HHS OIG\u0026rsquo;s health care, grant, and contractor self-disclosure protocols. Rob has been a frequent presenter for many years at major national healthcare and life sciences conferences, conveying the government\u0026rsquo;s enforcement and compliance priorities.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith over 25 years of experience, including as the former Chief Counsel to HHS OIG, Rob advises healthcare and life sciences companies on complex regulatory and compliance issues. As the highest-ranking attorney for OIG, Rob served as a nationwide expert on the federal government\u0026rsquo;s development and implementation of health care compliance strategies for health care entities and compliance oversight by health care boards of directors. Rob oversaw all OIG legal services related to audits, investigations, fraud enforcement, and industry guidance. From early in his career as a line attorney with primary responsibility for OIG\u0026rsquo;s pneumonia upcoding national project, Rob has been significantly involved in many of the federal government\u0026rsquo;s major healthcare fraud and compliance initiatives over the past 25 years. As Chief Counsel, Rob served as the lead Deputy Inspector General for OIG\u0026rsquo;s updated compliance program guidance documents, setting forth best practices for entities that do business with the Federal health care programs, including Medicare and Medicaid.\u003c/p\u003e\n\u003cp\u003eBefore his role as Chief Counsel, he served for more than a decade as an Assistant Inspector General (AIG) for Legal Affairs. In that position, he was the signatory for OIG advisory opinions on the application of OIG's fraud and abuse authorities, including under the AKS, to the requesting party's existing or proposed business arrangements. He was also responsible for leading OIG\u0026rsquo;s legal work related to waivers of certain fraud and abuse laws for purposes of testing new health care payment and service delivery models developed by CMS. He has led OIG\u0026rsquo;s negotiation of Corporate Integrity Agreements (CIAs), with a wide range of providers from across the health care industry. From 2012 to 2016, he served as the OIG signatory on behalf of HHS for all False Claims Act (including qui tam) settlements and CIAs nationwide.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to becoming AIG in 2012, Rob was the Chief of the Administrative and Civil Remedies Branch, the largest of three branches in the Office of Counsel.\u003c/p\u003e\n\u003cp\u003eIn 2007, Rob served as a Special Trial Attorney in DOJ\u0026rsquo;s Fraud Section, Criminal Division, where he prosecuted matters in connection with phase one of the Medicare Fraud Strike Force in the Southern District of Florida. In that role, Rob was co-counsel for the jury trial leading to conviction on all five criminal counts, including soliciting and receiving kickbacks, of a durable medical equipment company owner who conspired with two Miami pharmacies in a scheme to bill Medicare for expensive inhalation medications. Prior to working at OIG, he worked in the general counsel\u0026rsquo;s office at a managed care organization.\u003c/p\u003e","slug":"robert-deconti","email":"rdeconti@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":5,"source":"smartTags"}],"is_active":true,"last_name":"DeConti","nick_name":"Rob","clerkships":[],"first_name":"Robert","title_rank":9999,"updated_by":202,"law_schools":[{"id":3042,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1999-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"K.","name_suffix":"","recognitions":[{"title":"HHS Secretary’s Award for Distinguished Service","detail":""},{"title":"HHS Secretary’s Award for Meritorious Service","detail":""},{"title":"Inspector General’s Bronze Medal for Outstanding Employee of the Year (multiple awards)","detail":""},{"title":"Inspector General’s Award for Fighting Fraud, Waste, and Abuse","detail":""},{"title":"President’s Council on Integrity and Efficiency Award for Excellence","detail":""},{"title":"Office of Inspector General Cooperative Achievement Award (multiple awards)","detail":""},{"title":"Inspector General’s Exceptional Achievement Award (multiple awards)","detail":""}],"linked_in_url":"https://www.linkedin.com/in/robertdeconti","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRob DeConti is a partner in King \u0026amp; Spalding\u0026rsquo;s healthcare practice, specializing in government healthcare fraud investigations, compliance, diligence, the False Claims Act, the Anti-Kickback Statute (AKS), and regulatory compliance and enforcement issues in relation to healthcare transactions. Rob is an expert on all aspects of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) administrative remedies and initiatives, including mandatory and permissive exclusion authorities, the Civil Monetary Penalties Law, the Emergency Medical Treatment and Labor Act (EMTALA), corporate integrity agreements, Select Agent investigations, drug price reporting cases, and HHS OIG\u0026rsquo;s health care, grant, and contractor self-disclosure protocols. Rob has been a frequent presenter for many years at major national healthcare and life sciences conferences, conveying the government\u0026rsquo;s enforcement and compliance priorities.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith over 25 years of experience, including as the former Chief Counsel to HHS OIG, Rob advises healthcare and life sciences companies on complex regulatory and compliance issues. As the highest-ranking attorney for OIG, Rob served as a nationwide expert on the federal government\u0026rsquo;s development and implementation of health care compliance strategies for health care entities and compliance oversight by health care boards of directors. Rob oversaw all OIG legal services related to audits, investigations, fraud enforcement, and industry guidance. From early in his career as a line attorney with primary responsibility for OIG\u0026rsquo;s pneumonia upcoding national project, Rob has been significantly involved in many of the federal government\u0026rsquo;s major healthcare fraud and compliance initiatives over the past 25 years. As Chief Counsel, Rob served as the lead Deputy Inspector General for OIG\u0026rsquo;s updated compliance program guidance documents, setting forth best practices for entities that do business with the Federal health care programs, including Medicare and Medicaid.\u003c/p\u003e\n\u003cp\u003eBefore his role as Chief Counsel, he served for more than a decade as an Assistant Inspector General (AIG) for Legal Affairs. In that position, he was the signatory for OIG advisory opinions on the application of OIG's fraud and abuse authorities, including under the AKS, to the requesting party's existing or proposed business arrangements. He was also responsible for leading OIG\u0026rsquo;s legal work related to waivers of certain fraud and abuse laws for purposes of testing new health care payment and service delivery models developed by CMS. He has led OIG\u0026rsquo;s negotiation of Corporate Integrity Agreements (CIAs), with a wide range of providers from across the health care industry. From 2012 to 2016, he served as the OIG signatory on behalf of HHS for all False Claims Act (including qui tam) settlements and CIAs nationwide.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to becoming AIG in 2012, Rob was the Chief of the Administrative and Civil Remedies Branch, the largest of three branches in the Office of Counsel.\u003c/p\u003e\n\u003cp\u003eIn 2007, Rob served as a Special Trial Attorney in DOJ\u0026rsquo;s Fraud Section, Criminal Division, where he prosecuted matters in connection with phase one of the Medicare Fraud Strike Force in the Southern District of Florida. In that role, Rob was co-counsel for the jury trial leading to conviction on all five criminal counts, including soliciting and receiving kickbacks, of a durable medical equipment company owner who conspired with two Miami pharmacies in a scheme to bill Medicare for expensive inhalation medications. Prior to working at OIG, he worked in the general counsel\u0026rsquo;s office at a managed care organization.\u003c/p\u003e","recognitions":[{"title":"HHS Secretary’s Award for Distinguished Service","detail":""},{"title":"HHS Secretary’s Award for Meritorious Service","detail":""},{"title":"Inspector General’s Bronze Medal for Outstanding Employee of the Year (multiple awards)","detail":""},{"title":"Inspector General’s Award for Fighting Fraud, Waste, and Abuse","detail":""},{"title":"President’s Council on Integrity and Efficiency Award for Excellence","detail":""},{"title":"Office of Inspector General Cooperative Achievement Award (multiple awards)","detail":""},{"title":"Inspector General’s Exceptional Achievement Award (multiple awards)","detail":""}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12841}]},"capability_group_id":2},"created_at":"2025-12-05T05:02:32.000Z","updated_at":"2025-12-05T05:02:32.000Z","searchable_text":"DeConti{{ FIELD }}{:title=\u0026gt;\"HHS Secretary’s Award for Distinguished Service\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"HHS Secretary’s Award for Meritorious Service\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"Inspector General’s Bronze Medal for Outstanding Employee of the Year (multiple awards)\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"Inspector General’s Award for Fighting Fraud, Waste, and Abuse\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"President’s Council on Integrity and Efficiency Award for Excellence\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"Office of Inspector General Cooperative Achievement Award (multiple awards)\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"Inspector General’s Exceptional Achievement Award (multiple awards)\", :detail=\u0026gt;\"\"}{{ FIELD }}Rob DeConti is a partner in King \u0026amp; Spalding’s healthcare practice, specializing in government healthcare fraud investigations, compliance, diligence, the False Claims Act, the Anti-Kickback Statute (AKS), and regulatory compliance and enforcement issues in relation to healthcare transactions. Rob is an expert on all aspects of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) administrative remedies and initiatives, including mandatory and permissive exclusion authorities, the Civil Monetary Penalties Law, the Emergency Medical Treatment and Labor Act (EMTALA), corporate integrity agreements, Select Agent investigations, drug price reporting cases, and HHS OIG’s health care, grant, and contractor self-disclosure protocols. Rob has been a frequent presenter for many years at major national healthcare and life sciences conferences, conveying the government’s enforcement and compliance priorities. \nWith over 25 years of experience, including as the former Chief Counsel to HHS OIG, Rob advises healthcare and life sciences companies on complex regulatory and compliance issues. As the highest-ranking attorney for OIG, Rob served as a nationwide expert on the federal government’s development and implementation of health care compliance strategies for health care entities and compliance oversight by health care boards of directors. Rob oversaw all OIG legal services related to audits, investigations, fraud enforcement, and industry guidance. From early in his career as a line attorney with primary responsibility for OIG’s pneumonia upcoding national project, Rob has been significantly involved in many of the federal government’s major healthcare fraud and compliance initiatives over the past 25 years. As Chief Counsel, Rob served as the lead Deputy Inspector General for OIG’s updated compliance program guidance documents, setting forth best practices for entities that do business with the Federal health care programs, including Medicare and Medicaid.\nBefore his role as Chief Counsel, he served for more than a decade as an Assistant Inspector General (AIG) for Legal Affairs. In that position, he was the signatory for OIG advisory opinions on the application of OIG's fraud and abuse authorities, including under the AKS, to the requesting party's existing or proposed business arrangements. He was also responsible for leading OIG’s legal work related to waivers of certain fraud and abuse laws for purposes of testing new health care payment and service delivery models developed by CMS. He has led OIG’s negotiation of Corporate Integrity Agreements (CIAs), with a wide range of providers from across the health care industry. From 2012 to 2016, he served as the OIG signatory on behalf of HHS for all False Claims Act (including qui tam) settlements and CIAs nationwide. \nPrior to becoming AIG in 2012, Rob was the Chief of the Administrative and Civil Remedies Branch, the largest of three branches in the Office of Counsel.\nIn 2007, Rob served as a Special Trial Attorney in DOJ’s Fraud Section, Criminal Division, where he prosecuted matters in connection with phase one of the Medicare Fraud Strike Force in the Southern District of Florida. In that role, Rob was co-counsel for the jury trial leading to conviction on all five criminal counts, including soliciting and receiving kickbacks, of a durable medical equipment company owner who conspired with two Miami pharmacies in a scheme to bill Medicare for expensive inhalation medications. Prior to working at OIG, he worked in the general counsel’s office at a managed care organization. Partner HHS Secretary’s Award for Distinguished Service  HHS Secretary’s Award for Meritorious Service  Inspector General’s Bronze Medal for Outstanding Employee of the Year (multiple awards)  Inspector General’s Award for Fighting Fraud, Waste, and Abuse  President’s Council on Integrity and Efficiency Award for Excellence  Office of Inspector General Cooperative Achievement Award (multiple awards)  Inspector General’s Exceptional Achievement Award (multiple awards)  University of Virginia  American University Washington College of Law American University Washington College of Law District of Columbia Virginia Virginia State Bar American Health Law Association Government Attorney-at-Large, American Bar Association Health Law Section Council, 2022-2025 Government Liaison to the Health Care Compliance Association, Board of Directors, 2008-2012","searchable_name":"Robert K. DeConti (Rob)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426474,"version":1,"owner_type":"Person","owner_id":3794,"payload":{"bio":"\u003cp\u003eSam Diamant\u0026nbsp;represents\u0026nbsp;companies in high-stakes commercial disputes, including matters involving technology license disputes, false advertising, misappropriation of trade secrets, breach of fiduciary duty and various other business torts. \u0026nbsp;He has represented Fortune 500 and emerging companies alike in the technology, life sciences, financial services, and energy\u0026nbsp;industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBefore joining King \u0026amp; Spalding, Sam served as law clerk to United States Bankruptcy Judge William J. Lafferty in the Northern District of California. \u0026nbsp;\u003c/p\u003e","slug":"samuel-diamant","email":"sdiamant@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":38,"guid":"38.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":502,"guid":"502.smart_tags","index":4,"source":"smartTags"},{"id":1409,"guid":"1409.smart_tags","index":5,"source":"smartTags"}],"is_active":true,"last_name":"Diamant","nick_name":"Sam","clerkships":[{"name":"Law Clerk, William J. Lafferty, U.S. Bankruptcy Court for the Northern District of California","years_held":"2012-2014"}],"first_name":"Samuel","title_rank":9999,"updated_by":202,"law_schools":[{"id":2266,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2012-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":[{"title":"Top 40 Under 40","detail":"Daily Journal, 2024"},{"title":"Northern California Rising Star","detail":"Super Lawyers, 2021-2025"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eSam Diamant\u0026nbsp;represents\u0026nbsp;companies in high-stakes commercial disputes, including matters involving technology license disputes, false advertising, misappropriation of trade secrets, breach of fiduciary duty and various other business torts. \u0026nbsp;He has represented Fortune 500 and emerging companies alike in the technology, life sciences, financial services, and energy\u0026nbsp;industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBefore joining King \u0026amp; Spalding, Sam served as law clerk to United States Bankruptcy Judge William J. Lafferty in the Northern District of California. \u0026nbsp;\u003c/p\u003e","recognitions":[{"title":"Top 40 Under 40","detail":"Daily Journal, 2024"},{"title":"Northern California Rising Star","detail":"Super Lawyers, 2021-2025"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":819}]},"capability_group_id":3},"created_at":"2025-05-26T04:53:36.000Z","updated_at":"2025-05-26T04:53:36.000Z","searchable_text":"Diamant{{ FIELD }}{:title=\u0026gt;\"Top 40 Under 40\", :detail=\u0026gt;\"Daily Journal, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Northern California Rising Star\", :detail=\u0026gt;\"Super Lawyers, 2021-2025\"}{{ FIELD }}Sam Diamant represents companies in high-stakes commercial disputes, including matters involving technology license disputes, false advertising, misappropriation of trade secrets, breach of fiduciary duty and various other business torts.  He has represented Fortune 500 and emerging companies alike in the technology, life sciences, financial services, and energy industries.\nBefore joining King \u0026amp; Spalding, Sam served as law clerk to United States Bankruptcy Judge William J. Lafferty in the Northern District of California.   Partner Top 40 Under 40 Daily Journal, 2024 Northern California Rising Star Super Lawyers, 2021-2025 Davidson College  University of North Carolina at Chapel Hill University of North Carolina School of Law U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Northern District of Illinois U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California California U.S. Bankruptcy Court for the Eastern District of California Law Clerk, William J. Lafferty, U.S. Bankruptcy Court for the Northern District of California","searchable_name":"Samuel R. Diamant (Sam)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445683,"version":1,"owner_type":"Person","owner_id":7313,"payload":{"bio":"\u003cp\u003eAs a seasoned first-chair trial lawyer and former federal prosecutor, Tinos Diamantatos is a Fellow of the American College of Trial Lawyers, one of the premier, invitation-only legal associations in North America. He is ranked in \u003cem\u003eChambers USA\u003c/em\u003e and noted as \u0026ldquo;an outstanding trial lawyer\u0026rdquo; who is \u0026ldquo;a creative, forceful and tireless advocate\u0026rdquo; and \u0026ldquo;tremendous for clients and a good counselor.\u0026rdquo; He is listed in 2026 \u003cem\u003eLawdragon\u003c/em\u003e 500 Leading Litigators in America, is listed in \u003cem\u003eThe Best Lawyers in America\u003c/em\u003e for White-Collar Criminal Defense, and is recognized and recommended for dispute resolution, corporate investigations, and white-collar defense by the \u003cem\u003eLegal 500\u003c/em\u003e \u003cem\u003eUS\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eTinos is a premier courtroom advocate and trusted strategic advisor to corporations, boards, C-suites, senior executives, and individuals in their most consequential criminal, regulatory, and complex business litigation. This includes general litigation matters related to government investigations, \u003cem\u003equi tam\u003c/em\u003e litigation, government and internal investigations, and securities enforcement proceedings. He is recognized for leading high-stakes white-collar government enforcement, and complex commercial matters where the margin for error is zero and the cost of failure is existential.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eListed as one of \u003cem\u003eCrain\u0026rsquo;s Chicago Business\u003c/em\u003e \u0026ldquo;Notable Litigators and Trial Attorneys\u0026rdquo; for 2023, Tinos has tried more than 20 cases and achieved an outstanding record of success at trial. Tinos\u0026rsquo; trial representations span jurisdictions in both federal and state courts throughout the United States and have involved complex civil and criminal matters. Included among his trial successes are two separate trial wins for a Fortune 10 company.\u003c/p\u003e\n\u003cp\u003eTinos\u0026rsquo; representations span several industry sectors, including the retail, pharmaceutical, healthcare, pharmacy, medical device, and financial services industries. He has handled investigations, the defense, and prosecutions of matters involving alleged healthcare fraud, commodities fraud, mortgage fraud, money laundering, bank fraud, wire fraud, mail fraud, and tax evasion. He has also handled other complex matters involving terrorism, racketeering, extortion, corruption, obstruction, and civil rights violations.\u003c/p\u003e\n\u003cp\u003eTinos has been trusted by Fortune 500 companies, industry-leading pharmaceutical and healthcare companies, retail pharmacy chains, financial institutions, privately held businesses, and individuals in matters of utmost importance. He helps clients navigate government investigations, regulatory minefields, and related white collar litigation throughout the United States and around the world.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Tinos was a partner at an AmLaw 25 firm where he served as the Chicago office managing partner and as co-head of that firm\u0026rsquo;s global white collar and government investigations practice group. Before joining private practice, Tinos served as a federal prosecutor at the U.S. Attorney\u0026rsquo;s Office in Chicago where he successfully handled high-profile cases and trials that received national and international media attention. He also successfully served as lead appellate counsel representing the government on nine appeals before the U.S. Court of Appeals for the Second and Seventh Circuits. He served in a number of sections within the Chicago U.S. Attorney\u0026rsquo;s Office, including the Financial Crimes and Special Prosecutions Section, and the office\u0026rsquo;s Public Corruption and Organized Crime Section, where he completed his career as a prosecutor.\u003c/p\u003e\n\u003cp\u003eTinos is also a former federal judicial law clerk and a former president of the prestigious Chicago Inn of Court.\u0026nbsp;He maintains an active pro bono practice and is involved in multiple mentoring initiatives.\u0026nbsp;He is a former member of the John Marshall Law School Board of Trustees and has served as an adjunct trial advocacy professor for the law school, where he has coached many successful trial teams competing at the national level. He teaches, by invitation, law enforcement courses on trial techniques and investigative tactics to federal agents at their national training centers.\u0026nbsp;In 2025, the Hellenic Bar Association recognized him with its \u0026ldquo;Lawyer of the Year\u0026rdquo; Award.\u003c/p\u003e","slug":"tinos-diamantatos","email":"tdiamantatos@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eCommercial Litigation\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eDefending a major financial institution in a class action involving allegations related to purported violations of state statutes.\u003c/p\u003e","\u003cp\u003eDefending a publicly traded corporation in the managed services industry against allegations of contract fraud.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eFalse Claims Act/Qui Tam Litigation\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eDefending pharmaceutical companies in federal district court and state court in an action brought by a government entity alleging improper marketing of opioids. Recently successfully obtained dismissal of action.\u003c/p\u003e","\u003cp\u003eDefending ongoing FCA litigation for a national healthcare provider in federal district court following Department of Justice intervention on allegations related to improper physician billing.\u003c/p\u003e","\u003cp\u003eDefended pharmaceutical companies in multiple government investigations involving allegations related to off-label promotion and marketing practices.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCriminal Investigations\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresenting a large financial institution in connection with a Department of Justice inquiry.\u003c/p\u003e","\u003cp\u003eRepresenting multiple individual physicians in connection with various federal investigations of alleged healthcare fraud and improper billing practices.\u003c/p\u003e","\u003cp\u003eRepresenting an individual in a Department of Justice investigation into allegations of fraud and corruption.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eSecurities Fraud\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresenting a medical device manufacturer in connection with a Securities and Exchange Commission enforcement proceeding.\u003c/p\u003e","\u003cp\u003eRepresented individual under investigation for alleged insider trading. Matter recently closed by the Securities and Exchange Commission with no adverse action taken.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eInternal Investigations\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eConducted an internal investigation for multi-national corporation stemming from alleged violations of money laundering, structuring, and related financial reporting requirements.\u003c/p\u003e","\u003cp\u003eConducted a variety of internal investigations of potential abuse and procurement fraud.\u003c/p\u003e","\u003cp\u003eCounseled clients on FCPA issues and compliance programs.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":3,"source":"capabilities"},{"id":27,"guid":"27.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":6,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":7,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":8,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":9,"source":"capabilities"},{"id":1142,"guid":"1142.smart_tags","index":10,"source":"smartTags"},{"id":764,"guid":"764.smart_tags","index":11,"source":"smartTags"},{"id":952,"guid":"952.smart_tags","index":12,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":13,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":14,"source":"smartTags"},{"id":1715,"guid":"1715.smart_tags","index":15,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":16,"source":"smartTags"},{"id":762,"guid":"762.smart_tags","index":17,"source":"smartTags"}],"is_active":true,"last_name":"Diamantatos","nick_name":"Tinos","clerkships":[{"name":"Law Clerk, Judge Charles P. Kocoras, Northern District of Illinois","years_held":"2004 - 2005"}],"first_name":"Tinos","title_rank":9999,"updated_by":176,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Fellow","detail":"American College of Trial Lawyers"},{"title":"500 Leading Litigators in America","detail":"Lawdragon, 2026"},{"title":"Illinois Lawyer of the Year","detail":"Hellenic Bar Association, 2025"},{"title":"Notable Litigators and Trial Attorneys","detail":"Crain’s Chicago Business (2023)"},{"title":"Recognized for Criminal Defense: White-Collar, Chicago","detail":"The Best Lawyers in America, (2023–2025)"},{"title":"Litigation: White-Collar Crime \u0026 Government Investigations – Illinois","detail":"Chambers USA (2021–2025)"},{"title":"Up and Coming, Litigation: White-Collar Crime \u0026 Government Investigations – Illinois","detail":"Chambers USA (2020)"},{"title":"Dispute resolution: Corporate investigations and white-collar criminal defense","detail":"The Legal 500 US (2016, 2018–2025)"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAs a seasoned first-chair trial lawyer and former federal prosecutor, Tinos Diamantatos is a Fellow of the American College of Trial Lawyers, one of the premier, invitation-only legal associations in North America. He is ranked in \u003cem\u003eChambers USA\u003c/em\u003e and noted as \u0026ldquo;an outstanding trial lawyer\u0026rdquo; who is \u0026ldquo;a creative, forceful and tireless advocate\u0026rdquo; and \u0026ldquo;tremendous for clients and a good counselor.\u0026rdquo; He is listed in 2026 \u003cem\u003eLawdragon\u003c/em\u003e 500 Leading Litigators in America, is listed in \u003cem\u003eThe Best Lawyers in America\u003c/em\u003e for White-Collar Criminal Defense, and is recognized and recommended for dispute resolution, corporate investigations, and white-collar defense by the \u003cem\u003eLegal 500\u003c/em\u003e \u003cem\u003eUS\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eTinos is a premier courtroom advocate and trusted strategic advisor to corporations, boards, C-suites, senior executives, and individuals in their most consequential criminal, regulatory, and complex business litigation. This includes general litigation matters related to government investigations, \u003cem\u003equi tam\u003c/em\u003e litigation, government and internal investigations, and securities enforcement proceedings. He is recognized for leading high-stakes white-collar government enforcement, and complex commercial matters where the margin for error is zero and the cost of failure is existential.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eListed as one of \u003cem\u003eCrain\u0026rsquo;s Chicago Business\u003c/em\u003e \u0026ldquo;Notable Litigators and Trial Attorneys\u0026rdquo; for 2023, Tinos has tried more than 20 cases and achieved an outstanding record of success at trial. Tinos\u0026rsquo; trial representations span jurisdictions in both federal and state courts throughout the United States and have involved complex civil and criminal matters. Included among his trial successes are two separate trial wins for a Fortune 10 company.\u003c/p\u003e\n\u003cp\u003eTinos\u0026rsquo; representations span several industry sectors, including the retail, pharmaceutical, healthcare, pharmacy, medical device, and financial services industries. He has handled investigations, the defense, and prosecutions of matters involving alleged healthcare fraud, commodities fraud, mortgage fraud, money laundering, bank fraud, wire fraud, mail fraud, and tax evasion. He has also handled other complex matters involving terrorism, racketeering, extortion, corruption, obstruction, and civil rights violations.\u003c/p\u003e\n\u003cp\u003eTinos has been trusted by Fortune 500 companies, industry-leading pharmaceutical and healthcare companies, retail pharmacy chains, financial institutions, privately held businesses, and individuals in matters of utmost importance. He helps clients navigate government investigations, regulatory minefields, and related white collar litigation throughout the United States and around the world.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Tinos was a partner at an AmLaw 25 firm where he served as the Chicago office managing partner and as co-head of that firm\u0026rsquo;s global white collar and government investigations practice group. Before joining private practice, Tinos served as a federal prosecutor at the U.S. Attorney\u0026rsquo;s Office in Chicago where he successfully handled high-profile cases and trials that received national and international media attention. He also successfully served as lead appellate counsel representing the government on nine appeals before the U.S. Court of Appeals for the Second and Seventh Circuits. He served in a number of sections within the Chicago U.S. Attorney\u0026rsquo;s Office, including the Financial Crimes and Special Prosecutions Section, and the office\u0026rsquo;s Public Corruption and Organized Crime Section, where he completed his career as a prosecutor.\u003c/p\u003e\n\u003cp\u003eTinos is also a former federal judicial law clerk and a former president of the prestigious Chicago Inn of Court.\u0026nbsp;He maintains an active pro bono practice and is involved in multiple mentoring initiatives.\u0026nbsp;He is a former member of the John Marshall Law School Board of Trustees and has served as an adjunct trial advocacy professor for the law school, where he has coached many successful trial teams competing at the national level. He teaches, by invitation, law enforcement courses on trial techniques and investigative tactics to federal agents at their national training centers.\u0026nbsp;In 2025, the Hellenic Bar Association recognized him with its \u0026ldquo;Lawyer of the Year\u0026rdquo; Award.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eCommercial Litigation\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eDefending a major financial institution in a class action involving allegations related to purported violations of state statutes.\u003c/p\u003e","\u003cp\u003eDefending a publicly traded corporation in the managed services industry against allegations of contract fraud.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eFalse Claims Act/Qui Tam Litigation\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eDefending pharmaceutical companies in federal district court and state court in an action brought by a government entity alleging improper marketing of opioids. Recently successfully obtained dismissal of action.\u003c/p\u003e","\u003cp\u003eDefending ongoing FCA litigation for a national healthcare provider in federal district court following Department of Justice intervention on allegations related to improper physician billing.\u003c/p\u003e","\u003cp\u003eDefended pharmaceutical companies in multiple government investigations involving allegations related to off-label promotion and marketing practices.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eCriminal Investigations\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresenting a large financial institution in connection with a Department of Justice inquiry.\u003c/p\u003e","\u003cp\u003eRepresenting multiple individual physicians in connection with various federal investigations of alleged healthcare fraud and improper billing practices.\u003c/p\u003e","\u003cp\u003eRepresenting an individual in a Department of Justice investigation into allegations of fraud and corruption.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eSecurities Fraud\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresenting a medical device manufacturer in connection with a Securities and Exchange Commission enforcement proceeding.\u003c/p\u003e","\u003cp\u003eRepresented individual under investigation for alleged insider trading. Matter recently closed by the Securities and Exchange Commission with no adverse action taken.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eInternal Investigations\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eConducted an internal investigation for multi-national corporation stemming from alleged violations of money laundering, structuring, and related financial reporting requirements.\u003c/p\u003e","\u003cp\u003eConducted a variety of internal investigations of potential abuse and procurement fraud.\u003c/p\u003e","\u003cp\u003eCounseled clients on FCPA issues and compliance programs.\u003c/p\u003e"],"recognitions":[{"title":"Fellow","detail":"American College of Trial Lawyers"},{"title":"500 Leading Litigators in America","detail":"Lawdragon, 2026"},{"title":"Illinois Lawyer of the Year","detail":"Hellenic Bar Association, 2025"},{"title":"Notable Litigators and Trial Attorneys","detail":"Crain’s Chicago Business (2023)"},{"title":"Recognized for Criminal Defense: White-Collar, Chicago","detail":"The Best Lawyers in America, (2023–2025)"},{"title":"Litigation: White-Collar Crime \u0026 Government Investigations – Illinois","detail":"Chambers USA (2021–2025)"},{"title":"Up and Coming, Litigation: White-Collar Crime \u0026 Government Investigations – Illinois","detail":"Chambers USA (2020)"},{"title":"Dispute resolution: Corporate investigations and white-collar criminal defense","detail":"The Legal 500 US (2016, 2018–2025)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13354}]},"capability_group_id":3},"created_at":"2026-02-09T16:03:46.000Z","updated_at":"2026-02-09T16:03:46.000Z","searchable_text":"Diamantatos{{ FIELD }}{:title=\u0026gt;\"Fellow\", :detail=\u0026gt;\"American College of Trial Lawyers\"}{{ FIELD }}{:title=\u0026gt;\"500 Leading Litigators in America\", :detail=\u0026gt;\"Lawdragon, 2026\"}{{ FIELD }}{:title=\u0026gt;\"Illinois Lawyer of the Year\", :detail=\u0026gt;\"Hellenic Bar Association, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Notable Litigators and Trial Attorneys\", :detail=\u0026gt;\"Crain’s Chicago Business (2023)\"}{{ FIELD }}{:title=\u0026gt;\"Recognized for Criminal Defense: White-Collar, Chicago\", :detail=\u0026gt;\"The Best Lawyers in America, (2023–2025)\"}{{ FIELD }}{:title=\u0026gt;\"Litigation: White-Collar Crime \u0026amp; Government Investigations – Illinois\", :detail=\u0026gt;\"Chambers USA (2021–2025)\"}{{ FIELD }}{:title=\u0026gt;\"Up and Coming, Litigation: White-Collar Crime \u0026amp; Government Investigations – Illinois\", :detail=\u0026gt;\"Chambers USA (2020)\"}{{ FIELD }}{:title=\u0026gt;\"Dispute resolution: Corporate investigations and white-collar criminal defense\", :detail=\u0026gt;\"The Legal 500 US (2016, 2018–2025)\"}{{ FIELD }}Commercial Litigation{{ FIELD }}Defending a major financial institution in a class action involving allegations related to purported violations of state statutes.{{ FIELD }}Defending a publicly traded corporation in the managed services industry against allegations of contract fraud.{{ FIELD }}False Claims Act/Qui Tam Litigation{{ FIELD }}Defending pharmaceutical companies in federal district court and state court in an action brought by a government entity alleging improper marketing of opioids. Recently successfully obtained dismissal of action.{{ FIELD }}Defending ongoing FCA litigation for a national healthcare provider in federal district court following Department of Justice intervention on allegations related to improper physician billing.{{ FIELD }}Defended pharmaceutical companies in multiple government investigations involving allegations related to off-label promotion and marketing practices.{{ FIELD }}Criminal Investigations{{ FIELD }}Representing a large financial institution in connection with a Department of Justice inquiry.{{ FIELD }}Representing multiple individual physicians in connection with various federal investigations of alleged healthcare fraud and improper billing practices.{{ FIELD }}Representing an individual in a Department of Justice investigation into allegations of fraud and corruption.{{ FIELD }}Securities Fraud{{ FIELD }}Representing a medical device manufacturer in connection with a Securities and Exchange Commission enforcement proceeding.{{ FIELD }}Represented individual under investigation for alleged insider trading. Matter recently closed by the Securities and Exchange Commission with no adverse action taken.{{ FIELD }}Internal Investigations{{ FIELD }}Conducted an internal investigation for multi-national corporation stemming from alleged violations of money laundering, structuring, and related financial reporting requirements.{{ FIELD }}Conducted a variety of internal investigations of potential abuse and procurement fraud.{{ FIELD }}Counseled clients on FCPA issues and compliance programs.{{ FIELD }}As a seasoned first-chair trial lawyer and former federal prosecutor, Tinos Diamantatos is a Fellow of the American College of Trial Lawyers, one of the premier, invitation-only legal associations in North America. He is ranked in Chambers USA and noted as “an outstanding trial lawyer” who is “a creative, forceful and tireless advocate” and “tremendous for clients and a good counselor.” He is listed in 2026 Lawdragon 500 Leading Litigators in America, is listed in The Best Lawyers in America for White-Collar Criminal Defense, and is recognized and recommended for dispute resolution, corporate investigations, and white-collar defense by the Legal 500 US.\nTinos is a premier courtroom advocate and trusted strategic advisor to corporations, boards, C-suites, senior executives, and individuals in their most consequential criminal, regulatory, and complex business litigation. This includes general litigation matters related to government investigations, qui tam litigation, government and internal investigations, and securities enforcement proceedings. He is recognized for leading high-stakes white-collar government enforcement, and complex commercial matters where the margin for error is zero and the cost of failure is existential. \nListed as one of Crain’s Chicago Business “Notable Litigators and Trial Attorneys” for 2023, Tinos has tried more than 20 cases and achieved an outstanding record of success at trial. Tinos’ trial representations span jurisdictions in both federal and state courts throughout the United States and have involved complex civil and criminal matters. Included among his trial successes are two separate trial wins for a Fortune 10 company.\nTinos’ representations span several industry sectors, including the retail, pharmaceutical, healthcare, pharmacy, medical device, and financial services industries. He has handled investigations, the defense, and prosecutions of matters involving alleged healthcare fraud, commodities fraud, mortgage fraud, money laundering, bank fraud, wire fraud, mail fraud, and tax evasion. He has also handled other complex matters involving terrorism, racketeering, extortion, corruption, obstruction, and civil rights violations.\nTinos has been trusted by Fortune 500 companies, industry-leading pharmaceutical and healthcare companies, retail pharmacy chains, financial institutions, privately held businesses, and individuals in matters of utmost importance. He helps clients navigate government investigations, regulatory minefields, and related white collar litigation throughout the United States and around the world.\nPrior to joining King \u0026amp; Spalding, Tinos was a partner at an AmLaw 25 firm where he served as the Chicago office managing partner and as co-head of that firm’s global white collar and government investigations practice group. Before joining private practice, Tinos served as a federal prosecutor at the U.S. Attorney’s Office in Chicago where he successfully handled high-profile cases and trials that received national and international media attention. He also successfully served as lead appellate counsel representing the government on nine appeals before the U.S. Court of Appeals for the Second and Seventh Circuits. He served in a number of sections within the Chicago U.S. Attorney’s Office, including the Financial Crimes and Special Prosecutions Section, and the office’s Public Corruption and Organized Crime Section, where he completed his career as a prosecutor.\nTinos is also a former federal judicial law clerk and a former president of the prestigious Chicago Inn of Court. He maintains an active pro bono practice and is involved in multiple mentoring initiatives. He is a former member of the John Marshall Law School Board of Trustees and has served as an adjunct trial advocacy professor for the law school, where he has coached many successful trial teams competing at the national level. He teaches, by invitation, law enforcement courses on trial techniques and investigative tactics to federal agents at their national training centers. In 2025, the Hellenic Bar Association recognized him with its “Lawyer of the Year” Award. Partner Fellow American College of Trial Lawyers 500 Leading Litigators in America Lawdragon, 2026 Illinois Lawyer of the Year Hellenic Bar Association, 2025 Notable Litigators and Trial Attorneys Crain’s Chicago Business (2023) Recognized for Criminal Defense: White-Collar, Chicago The Best Lawyers in America, (2023–2025) Litigation: White-Collar Crime \u0026amp; Government Investigations – Illinois Chambers USA (2021–2025) Up and Coming, Litigation: White-Collar Crime \u0026amp; Government Investigations – Illinois Chambers USA (2020) Dispute resolution: Corporate investigations and white-collar criminal defense The Legal 500 US (2016, 2018–2025) DePaul University DePaul University College of Law The John Marshall Law School The John Marshall Law School U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Seventh Circuit Illinois Member, American Bar Association Member, Federal Bar Association Member, Chicago Bar Association President, Chicago Inn of Court (2017–2018) Member, Seventh Circuit Bar Association Member, Hellenic Bar Association Member, The John Marshall Law School Board of Trustees Member, Order of John Marshall Law Clerk, Judge Charles P. Kocoras, Northern District of Illinois Commercial Litigation Defending a major financial institution in a class action involving allegations related to purported violations of state statutes. Defending a publicly traded corporation in the managed services industry against allegations of contract fraud. False Claims Act/Qui Tam Litigation Defending pharmaceutical companies in federal district court and state court in an action brought by a government entity alleging improper marketing of opioids. Recently successfully obtained dismissal of action. Defending ongoing FCA litigation for a national healthcare provider in federal district court following Department of Justice intervention on allegations related to improper physician billing. Defended pharmaceutical companies in multiple government investigations involving allegations related to off-label promotion and marketing practices. Criminal Investigations Representing a large financial institution in connection with a Department of Justice inquiry. Representing multiple individual physicians in connection with various federal investigations of alleged healthcare fraud and improper billing practices. Representing an individual in a Department of Justice investigation into allegations of fraud and corruption. Securities Fraud Representing a medical device manufacturer in connection with a Securities and Exchange Commission enforcement proceeding. Represented individual under investigation for alleged insider trading. Matter recently closed by the Securities and Exchange Commission with no adverse action taken. Internal Investigations Conducted an internal investigation for multi-national corporation stemming from alleged violations of money laundering, structuring, and related financial reporting requirements. Conducted a variety of internal investigations of potential abuse and procurement fraud. Counseled clients on FCPA issues and compliance programs.","searchable_name":"Tinos Diamantatos","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":176,"capability_group_featured":null,"home_page_featured":null},{"id":444013,"version":1,"owner_type":"Person","owner_id":7224,"payload":{"bio":"\u003cp\u003eWith 15 years of experience, Amadou\u0026rsquo;s practice focusses on patent and trade secret litigation matters for innovative technology companies. Amadou\u0026rsquo;s clients span numerous industries in the technology sector including data analytics, AI, cloud computing, cryptocurrency, search engine, web accessibility, wireless networking, finance, consumer products, and apparel. Amadou\u0026rsquo;s clients span the full spectrum of the corporate lifecycle from Fortune 100 companies to C-suite executives to individual founders and startups. Amadou is acutely aware of the unique needs of clients at different stages of their corporate trajectory and tailors his approach to each matter with this in mind.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmadou\u0026rsquo;s experience spans all stages of litigation, arbitration, and mediation through trial and other contested proceeding. He has extensive experience in numerous jurisdictions across the country including federal district courts, the International Trade Commission, the PTAB, and various arbitration tribunals. Amadou leverages his deep experience across numerous jurisdictions to develop holistic approaches for clients involved in complex multi-faceted litigations.\u003c/p\u003e\n\u003cp\u003eFor startup and earlier stage clients, Amadou serves as a strategic advisor on key intellectual property issues like freedom to operate, brand protection, patent portfolio development, trade secret protection, and licensing matters.\u003c/p\u003e\n\u003cp\u003eAmadou also counsels clients on a range of strategic IP dispute issues related to risk avoidance, mergers and acquisitions and other transactional matters.\u003c/p\u003e\n\u003cp\u003eAmadou routinely presents continuing legal education programs to clients on a broad array of issues related to IP, equity and inclusion in the legal profession and welcomes the opportunity to interface with clients through this programming. He is committed to civic engagement and has over a decade of experience serving on non-profit boards.\u003c/p\u003e\n\u003cp\u003eIn recognition of his dedication to client service, the National Law Journal recognized Amadou as a Rising Star in 2024. In 2024, Amadou was also recognized by the Legal 500 US as recommended Lawyer for his work in Patent Litigation: Full Coverage. Super Lawyers has recognized Amadou as a Rising Star and Top-Rated Intellectual Property Litigator each year since 2017.\u003c/p\u003e","slug":"amadou-diaw","email":"adiaw@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem\u003ePRCM Advisers LLC, et al. v. Two Harbors Investment Corp., \u003c/em\u003eCase No. 20-cv-5649 (S.D.N.Y.) Representing Two Harbors Investment Corporation in a multi-faceted dispute involving claims for trade secret misappropriation.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eAudioEye, Inc. v. accessiBe Ltd.\u003c/em\u003e, Case No. 6:20-cv-997 (W.D. Tex.) Represented accessiBe in patent infringement litigation related to web accessibility technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn the Matter of Certain Computing Devices Utilizing Indexed Search Systems and Components Thereof\u003c/em\u003e, case number 337-TA-1389 represented the complainant X1 Discovery in a patent infringement litigation related to the use of certain index-based search technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eTQ Delta, LLC v. CommScope Holding Company, Inc. et al\u003c/em\u003e., Case No. 2:21-cv-310 (E.D. Tex.) Represented CommScope in patent infringement litigation related to certain signal impulse noise control and modulation technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eWeb 2.0 Technologies LLC v. Zendesk Inc.\u003c/em\u003e, Case No. 1:23-cv-00105 (D. Del.) Represented Zendesk in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eWeb 2.0 Technologies, LLC v. 37signals LLC., d/b/a Basecamp\u003c/em\u003e, Case No. 1:23-cv-230 (N.D. Ill.) Represented Basecamp in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eEasyweb Innovations LLC v. Bitpay Inc.\u003c/em\u003e, Case No. 1:24-cv-8582 (S.D.N.Y.) Represented BitPay in patent infringement litigation related to two-factor authentication technology.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":6,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":7,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":8,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":9,"source":"capabilities"},{"id":763,"guid":"763.smart_tags","index":10,"source":"smartTags"},{"id":1409,"guid":"1409.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Diaw","nick_name":"Amadou","clerkships":[],"first_name":"Amadou","title_rank":9999,"updated_by":202,"law_schools":[{"id":2410,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2009-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Kilkenny","name_suffix":"","recognitions":[{"title":"Rising Star in DC","detail":"National Law Journal, 2024"},{"title":"Recognized Amadou as a recommended Lawyer for his work in Patent Litigation: Full Coverage ","detail":"Legal 500 US, 2024"},{"title":"Rising Star and Top-Rated Intellectual Property Attorney in DC","detail":"Super Lawyers, 2017-Present"},{"title":"Outstanding Achievement Award","detail":"Washington Lawyers’ Committee for Civil Rights and Urban Affairs"}],"linked_in_url":"https://www.linkedin.com/in/akd44/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eWith 15 years of experience, Amadou\u0026rsquo;s practice focusses on patent and trade secret litigation matters for innovative technology companies. Amadou\u0026rsquo;s clients span numerous industries in the technology sector including data analytics, AI, cloud computing, cryptocurrency, search engine, web accessibility, wireless networking, finance, consumer products, and apparel. Amadou\u0026rsquo;s clients span the full spectrum of the corporate lifecycle from Fortune 100 companies to C-suite executives to individual founders and startups. Amadou is acutely aware of the unique needs of clients at different stages of their corporate trajectory and tailors his approach to each matter with this in mind.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmadou\u0026rsquo;s experience spans all stages of litigation, arbitration, and mediation through trial and other contested proceeding. He has extensive experience in numerous jurisdictions across the country including federal district courts, the International Trade Commission, the PTAB, and various arbitration tribunals. Amadou leverages his deep experience across numerous jurisdictions to develop holistic approaches for clients involved in complex multi-faceted litigations.\u003c/p\u003e\n\u003cp\u003eFor startup and earlier stage clients, Amadou serves as a strategic advisor on key intellectual property issues like freedom to operate, brand protection, patent portfolio development, trade secret protection, and licensing matters.\u003c/p\u003e\n\u003cp\u003eAmadou also counsels clients on a range of strategic IP dispute issues related to risk avoidance, mergers and acquisitions and other transactional matters.\u003c/p\u003e\n\u003cp\u003eAmadou routinely presents continuing legal education programs to clients on a broad array of issues related to IP, equity and inclusion in the legal profession and welcomes the opportunity to interface with clients through this programming. He is committed to civic engagement and has over a decade of experience serving on non-profit boards.\u003c/p\u003e\n\u003cp\u003eIn recognition of his dedication to client service, the National Law Journal recognized Amadou as a Rising Star in 2024. In 2024, Amadou was also recognized by the Legal 500 US as recommended Lawyer for his work in Patent Litigation: Full Coverage. Super Lawyers has recognized Amadou as a Rising Star and Top-Rated Intellectual Property Litigator each year since 2017.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem\u003ePRCM Advisers LLC, et al. v. Two Harbors Investment Corp., \u003c/em\u003eCase No. 20-cv-5649 (S.D.N.Y.) Representing Two Harbors Investment Corporation in a multi-faceted dispute involving claims for trade secret misappropriation.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eAudioEye, Inc. v. accessiBe Ltd.\u003c/em\u003e, Case No. 6:20-cv-997 (W.D. Tex.) Represented accessiBe in patent infringement litigation related to web accessibility technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eIn the Matter of Certain Computing Devices Utilizing Indexed Search Systems and Components Thereof\u003c/em\u003e, case number 337-TA-1389 represented the complainant X1 Discovery in a patent infringement litigation related to the use of certain index-based search technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eTQ Delta, LLC v. CommScope Holding Company, Inc. et al\u003c/em\u003e., Case No. 2:21-cv-310 (E.D. Tex.) Represented CommScope in patent infringement litigation related to certain signal impulse noise control and modulation technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eWeb 2.0 Technologies LLC v. Zendesk Inc.\u003c/em\u003e, Case No. 1:23-cv-00105 (D. Del.) Represented Zendesk in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eWeb 2.0 Technologies, LLC v. 37signals LLC., d/b/a Basecamp\u003c/em\u003e, Case No. 1:23-cv-230 (N.D. Ill.) Represented Basecamp in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eEasyweb Innovations LLC v. Bitpay Inc.\u003c/em\u003e, Case No. 1:24-cv-8582 (S.D.N.Y.) Represented BitPay in patent infringement litigation related to two-factor authentication technology.\u003c/p\u003e"],"recognitions":[{"title":"Rising Star in DC","detail":"National Law Journal, 2024"},{"title":"Recognized Amadou as a recommended Lawyer for his work in Patent Litigation: Full Coverage ","detail":"Legal 500 US, 2024"},{"title":"Rising Star and Top-Rated Intellectual Property Attorney in DC","detail":"Super Lawyers, 2017-Present"},{"title":"Outstanding Achievement Award","detail":"Washington Lawyers’ Committee for Civil Rights and Urban Affairs"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12964}]},"capability_group_id":3},"created_at":"2025-12-05T05:02:42.000Z","updated_at":"2025-12-05T05:02:42.000Z","searchable_text":"Diaw{{ FIELD }}{:title=\u0026gt;\"Rising Star in DC\", :detail=\u0026gt;\"National Law Journal, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recognized Amadou as a recommended Lawyer for his work in Patent Litigation: Full Coverage \", :detail=\u0026gt;\"Legal 500 US, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star and Top-Rated Intellectual Property Attorney in DC\", :detail=\u0026gt;\"Super Lawyers, 2017-Present\"}{{ FIELD }}{:title=\u0026gt;\"Outstanding Achievement Award\", :detail=\u0026gt;\"Washington Lawyers’ Committee for Civil Rights and Urban Affairs\"}{{ FIELD }}PRCM Advisers LLC, et al. v. Two Harbors Investment Corp., Case No. 20-cv-5649 (S.D.N.Y.) Representing Two Harbors Investment Corporation in a multi-faceted dispute involving claims for trade secret misappropriation.{{ FIELD }}AudioEye, Inc. v. accessiBe Ltd., Case No. 6:20-cv-997 (W.D. Tex.) Represented accessiBe in patent infringement litigation related to web accessibility technology.{{ FIELD }}In the Matter of Certain Computing Devices Utilizing Indexed Search Systems and Components Thereof, case number 337-TA-1389 represented the complainant X1 Discovery in a patent infringement litigation related to the use of certain index-based search technology.{{ FIELD }}TQ Delta, LLC v. CommScope Holding Company, Inc. et al., Case No. 2:21-cv-310 (E.D. Tex.) Represented CommScope in patent infringement litigation related to certain signal impulse noise control and modulation technology.{{ FIELD }}Web 2.0 Technologies LLC v. Zendesk Inc., Case No. 1:23-cv-00105 (D. Del.) Represented Zendesk in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration.{{ FIELD }}Web 2.0 Technologies, LLC v. 37signals LLC., d/b/a Basecamp, Case No. 1:23-cv-230 (N.D. Ill.) Represented Basecamp in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration.{{ FIELD }}Easyweb Innovations LLC v. Bitpay Inc., Case No. 1:24-cv-8582 (S.D.N.Y.) Represented BitPay in patent infringement litigation related to two-factor authentication technology.{{ FIELD }}With 15 years of experience, Amadou’s practice focusses on patent and trade secret litigation matters for innovative technology companies. Amadou’s clients span numerous industries in the technology sector including data analytics, AI, cloud computing, cryptocurrency, search engine, web accessibility, wireless networking, finance, consumer products, and apparel. Amadou’s clients span the full spectrum of the corporate lifecycle from Fortune 100 companies to C-suite executives to individual founders and startups. Amadou is acutely aware of the unique needs of clients at different stages of their corporate trajectory and tailors his approach to each matter with this in mind. \nAmadou’s experience spans all stages of litigation, arbitration, and mediation through trial and other contested proceeding. He has extensive experience in numerous jurisdictions across the country including federal district courts, the International Trade Commission, the PTAB, and various arbitration tribunals. Amadou leverages his deep experience across numerous jurisdictions to develop holistic approaches for clients involved in complex multi-faceted litigations.\nFor startup and earlier stage clients, Amadou serves as a strategic advisor on key intellectual property issues like freedom to operate, brand protection, patent portfolio development, trade secret protection, and licensing matters.\nAmadou also counsels clients on a range of strategic IP dispute issues related to risk avoidance, mergers and acquisitions and other transactional matters.\nAmadou routinely presents continuing legal education programs to clients on a broad array of issues related to IP, equity and inclusion in the legal profession and welcomes the opportunity to interface with clients through this programming. He is committed to civic engagement and has over a decade of experience serving on non-profit boards.\nIn recognition of his dedication to client service, the National Law Journal recognized Amadou as a Rising Star in 2024. In 2024, Amadou was also recognized by the Legal 500 US as recommended Lawyer for his work in Patent Litigation: Full Coverage. Super Lawyers has recognized Amadou as a Rising Star and Top-Rated Intellectual Property Litigator each year since 2017. Partner Rising Star in DC National Law Journal, 2024 Recognized Amadou as a recommended Lawyer for his work in Patent Litigation: Full Coverage  Legal 500 US, 2024 Rising Star and Top-Rated Intellectual Property Attorney in DC Super Lawyers, 2017-Present Outstanding Achievement Award Washington Lawyers’ Committee for Civil Rights and Urban Affairs Georgetown University  University of Virginia University of Virginia School of Law Maryland State Bar Association National Bar Association Washington D.C. Bar Association Intellectual Property Owners Association Board of Strength in Numbers DC, Board Member Georgetown University’s Hoya Hoop Club, Secretary of the Board of Directors Hoyas Unlimited, At-Large Board Member University of Virginia School of Law Foundation, Class Agent PRCM Advisers LLC, et al. v. Two Harbors Investment Corp., Case No. 20-cv-5649 (S.D.N.Y.) Representing Two Harbors Investment Corporation in a multi-faceted dispute involving claims for trade secret misappropriation. AudioEye, Inc. v. accessiBe Ltd., Case No. 6:20-cv-997 (W.D. Tex.) Represented accessiBe in patent infringement litigation related to web accessibility technology. In the Matter of Certain Computing Devices Utilizing Indexed Search Systems and Components Thereof, case number 337-TA-1389 represented the complainant X1 Discovery in a patent infringement litigation related to the use of certain index-based search technology. TQ Delta, LLC v. CommScope Holding Company, Inc. et al., Case No. 2:21-cv-310 (E.D. Tex.) Represented CommScope in patent infringement litigation related to certain signal impulse noise control and modulation technology. Web 2.0 Technologies LLC v. Zendesk Inc., Case No. 1:23-cv-00105 (D. Del.) Represented Zendesk in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration. Web 2.0 Technologies, LLC v. 37signals LLC., d/b/a Basecamp, Case No. 1:23-cv-230 (N.D. Ill.) Represented Basecamp in a patent infringement litigation related to cybersecurity techniques used in connection with online document collaboration. Easyweb Innovations LLC v. Bitpay Inc., Case No. 1:24-cv-8582 (S.D.N.Y.) Represented BitPay in patent infringement litigation related to two-factor authentication technology.","searchable_name":"Amadou Kilkenny Diaw","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":435271,"version":1,"owner_type":"Person","owner_id":1973,"payload":{"bio":"\u003cp\u003eDan Donovan specializes in congressional, state attorneys general and parallel government investigations. A former Chief Investigative Counsel in the Senate, Dan co-chairs\u0026nbsp;our Government Advocacy and Congressional Investigations practices perennially recognized by \u003cem\u003eChambers USA\u003c/em\u003e: \u0026ldquo;King \u0026amp; Spalding is best known for its impressive congressional investigations practice, with several dedicated members working exclusively in this area.\u0026rdquo; Dan is ranked Band 1 for Congressional Investigations by \u003cem\u003eChambers USA \u003c/em\u003eand Tier 1 \u003cem\u003eLegal 500 US\u003c/em\u003e.\u0026nbsp; He\u0026nbsp;has two decades of crisis management experience with government investigations, involving significant legal, public relations and political risks.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDan represents leading companies, individuals, trade associations, and nonprofit entities and provides effective crisis management counsel. He works at the forefront of controversial and politicized national and state policy issues that frequently lead to investigations and litigation, including congressional, multi-state and federal agency enforcement actions. Particularly experienced in anticipating and responding to congressional committee requests and subpoenas, Dan prepares clients for high-profile hearings and guides them through the unique challenges presented by congressional and parallel government investigations.\u003c/p\u003e\n\u003cp\u003eBefore joining the firm, Dan served as Senior Investigative Counsel to Senator Charles Grassley, then Chairman of the Committee on Finance. While serving in the U.S. Senate, Dan managed congressional investigations and oversight hearings. In this role, Dan directed investigations focused on statutory and regulatory compliance, including drug and device safety, drug pricing, and waste, fraud and abuse in Medicare, Medicaid and other government programs. He also handled policy and legislative matters, including the False Claims Act, the Food, Drug, and Cosmetic Act, Medicare and Medicaid programs, and related statutes. Dan also served as Chief Investigative Counsel to the Senate Committee on Small Business, where he managed consumer fraud and small business protection investigations and hearings. He began his congressional career as a Staff Assistant on the Senate Committee on Governmental Affairs, chaired by Senator Fred Thompson, working on the special investigation into the 1996 federal election campaigns.\u003c/p\u003e\n\u003cp\u003eDan also provides strategic policy and legislative counsel, and is a frequent speaker on congressional oversight and investigations.\u003c/p\u003e","slug":"daniel-donovan","email":"ddonovan@kslaw.com","phone":null,"matters":["\u003cp\u003eExperience representing numerous clients under investigation by Republican-controlled Senate and House Committees, including Senate Banking, Commerce, Finance, HELP, Homeland Security, Judiciary, Permanent Subcommittee on Investigations, Special Committee on Aging, and House Education and the Workforce, Energy \u0026amp; Commerce, Financial Services, Judiciary, Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, Select Committee on CCP, and Ways \u0026amp; Means, among others.\u003c/p\u003e","\u003cp\u003eProviding advice and counsel with respect to congressional oversight activity to leading companies in private sector industries, including accounting, auto, banking, consulting, defense, energy, fashion, food, healthcare provider, higher education, insurance, medical device, pharmaceutical, private equity, and tech, among others.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ea variety of clients\u003c/strong\u003e\u0026nbsp;in connection with investigations relating to allegations of government fraud, food and product safety and recalls, cybersecurity breaches, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emultiple pharmaceutical companies\u003c/strong\u003e\u0026nbsp;in connection with congressional and state attorneys general drug pricing investigations.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea variety of clients\u003c/strong\u003e\u0026nbsp;on healthcare policy and legislative issues.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea major university\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e\u0026nbsp;in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea global financial institution\u003c/strong\u003e\u0026nbsp;in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea Big Four accounting firm\u003c/strong\u003e\u0026nbsp;in a Senate Finance Committee investigation of a University\u0026rsquo;s handling of federal funds.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emultiple pharmaceutical companies\u003c/strong\u003e\u0026nbsp;in House and Senate investigations related to Affordable Care Act enactment and implementation.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emedical device companies\u003c/strong\u003e\u0026nbsp;in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea leading clean energy technology company\u003c/strong\u003e\u0026nbsp;in connection with a Senate investigation into Department of Energy grant program.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea major oil company\u003c/strong\u003e\u0026nbsp;in connection with congressional investigations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea health insurer\u003c/strong\u003e\u0026nbsp;in House and Senate investigations related to Affordable Care Act implementation.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea coalition of food product companies\u003c/strong\u003e\u0026nbsp;in connection with congressional inquiries relating to food safety and regulatory issues.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea medical society\u003c/strong\u003e\u0026nbsp;in connection with Senate committee investigations in payments to physicians.\u003c/p\u003e","\u003cp\u003eRepresented individuals in connection with House and Senate committee inquiries and ethics investigations.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3464}]},"expertise":[{"id":23,"guid":"23.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":2,"source":"smartTags"},{"id":111,"guid":"111.capabilities","index":3,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":4,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":5,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":6,"source":"capabilities"},{"id":71,"guid":"71.capabilities","index":7,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":8,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":9,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":10,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":11,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":12,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":13,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":14,"source":"capabilities"},{"id":128,"guid":"128.capabilities","index":15,"source":"capabilities"},{"id":1261,"guid":"1261.smart_tags","index":16,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":17,"source":"smartTags"}],"is_active":true,"last_name":"Donovan","nick_name":"Dan","clerkships":[],"first_name":"Daniel","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"F.","name_suffix":"","recognitions":[{"title":"Band 1 Top Ranked Lawyer, Government Relations: Congressional Investigations - USA - Nationwide","detail":"Chambers USA, 2021-2024"},{"title":"“[Daniel] provides superb service and is an absolutely indispensable partner. He is incredibly responsive.”","detail":"Chambers USA"},{"title":"Tier 1 Government Relations: Congressional Investigations","detail":"Legal 500 US, 2024"},{"title":"“Life Sciences Star” White-Collar/Govt. Investigations","detail":"LMG Life Sciences, 2024"},{"title":"GIR 100","detail":"Global Investigations Review, 2024"},{"title":"Tier 1 for Government Relations Practice","detail":"Best Lawyers, 2024"},{"title":"“[W]e have complete confidence in his ability to manage complex issues and communicate with our senior leaders.”","detail":"Chambers USA"},{"title":"“King \u0026 Spalding is best known for its impressive congressional investigations practice.”","detail":"Chambers USA, 2008-2024"},{"title":"“Daniel is an expert in Congressional investigations and is always able to keep a calm head”","detail":"Chambers USA, 2021-2024"},{"title":"“Daniel provides extremely good insight into the Congressional process and can convey it to high-level executives.”","detail":"Chambers USA"},{"title":"“[A]ctive in high-profile congressional investigations, and includes ... experts such as Daniel Donovan”","detail":"Legal 500 US"},{"title":"King \u0026 Spalding has “a strong track in congressional investigations … Daniel Donovan is a key contact”","detail":"Legal 500 US"},{"title":"Nationwide Government Relations Practice Ranking","detail":"Chambers USA 2008-2024"},{"title":"Leading Government Relations Lawyer","detail":"Legal 500 US, 2020-2024"},{"title":"Crisis Management and Government Oversight Practice Award","detail":"National Law Journal 2021"},{"title":"“Law Firm of the Year” for Government Relations","detail":"US News \u0026 World Report"}],"linked_in_url":"https://www.linkedin.com/in/dan-donovan-214322a/","seodescription":"Dan Donovan specializes in congressional, state attorneys general and parallel government investigations. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDan Donovan specializes in congressional, state attorneys general and parallel government investigations. A former Chief Investigative Counsel in the Senate, Dan co-chairs\u0026nbsp;our Government Advocacy and Congressional Investigations practices perennially recognized by \u003cem\u003eChambers USA\u003c/em\u003e: \u0026ldquo;King \u0026amp; Spalding is best known for its impressive congressional investigations practice, with several dedicated members working exclusively in this area.\u0026rdquo; Dan is ranked Band 1 for Congressional Investigations by \u003cem\u003eChambers USA \u003c/em\u003eand Tier 1 \u003cem\u003eLegal 500 US\u003c/em\u003e.\u0026nbsp; He\u0026nbsp;has two decades of crisis management experience with government investigations, involving significant legal, public relations and political risks.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDan represents leading companies, individuals, trade associations, and nonprofit entities and provides effective crisis management counsel. He works at the forefront of controversial and politicized national and state policy issues that frequently lead to investigations and litigation, including congressional, multi-state and federal agency enforcement actions. Particularly experienced in anticipating and responding to congressional committee requests and subpoenas, Dan prepares clients for high-profile hearings and guides them through the unique challenges presented by congressional and parallel government investigations.\u003c/p\u003e\n\u003cp\u003eBefore joining the firm, Dan served as Senior Investigative Counsel to Senator Charles Grassley, then Chairman of the Committee on Finance. While serving in the U.S. Senate, Dan managed congressional investigations and oversight hearings. In this role, Dan directed investigations focused on statutory and regulatory compliance, including drug and device safety, drug pricing, and waste, fraud and abuse in Medicare, Medicaid and other government programs. He also handled policy and legislative matters, including the False Claims Act, the Food, Drug, and Cosmetic Act, Medicare and Medicaid programs, and related statutes. Dan also served as Chief Investigative Counsel to the Senate Committee on Small Business, where he managed consumer fraud and small business protection investigations and hearings. He began his congressional career as a Staff Assistant on the Senate Committee on Governmental Affairs, chaired by Senator Fred Thompson, working on the special investigation into the 1996 federal election campaigns.\u003c/p\u003e\n\u003cp\u003eDan also provides strategic policy and legislative counsel, and is a frequent speaker on congressional oversight and investigations.\u003c/p\u003e","matters":["\u003cp\u003eExperience representing numerous clients under investigation by Republican-controlled Senate and House Committees, including Senate Banking, Commerce, Finance, HELP, Homeland Security, Judiciary, Permanent Subcommittee on Investigations, Special Committee on Aging, and House Education and the Workforce, Energy \u0026amp; Commerce, Financial Services, Judiciary, Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, Select Committee on CCP, and Ways \u0026amp; Means, among others.\u003c/p\u003e","\u003cp\u003eProviding advice and counsel with respect to congressional oversight activity to leading companies in private sector industries, including accounting, auto, banking, consulting, defense, energy, fashion, food, healthcare provider, higher education, insurance, medical device, pharmaceutical, private equity, and tech, among others.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ea variety of clients\u003c/strong\u003e\u0026nbsp;in connection with investigations relating to allegations of government fraud, food and product safety and recalls, cybersecurity breaches, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emultiple pharmaceutical companies\u003c/strong\u003e\u0026nbsp;in connection with congressional and state attorneys general drug pricing investigations.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea variety of clients\u003c/strong\u003e\u0026nbsp;on healthcare policy and legislative issues.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea major university\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e\u0026nbsp;in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea global financial institution\u003c/strong\u003e\u0026nbsp;in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea Big Four accounting firm\u003c/strong\u003e\u0026nbsp;in a Senate Finance Committee investigation of a University\u0026rsquo;s handling of federal funds.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emultiple pharmaceutical companies\u003c/strong\u003e\u0026nbsp;in House and Senate investigations related to Affordable Care Act enactment and implementation.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emedical device companies\u003c/strong\u003e\u0026nbsp;in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea leading clean energy technology company\u003c/strong\u003e\u0026nbsp;in connection with a Senate investigation into Department of Energy grant program.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea major oil company\u003c/strong\u003e\u0026nbsp;in connection with congressional investigations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea health insurer\u003c/strong\u003e\u0026nbsp;in House and Senate investigations related to Affordable Care Act implementation.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea coalition of food product companies\u003c/strong\u003e\u0026nbsp;in connection with congressional inquiries relating to food safety and regulatory issues.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea medical society\u003c/strong\u003e\u0026nbsp;in connection with Senate committee investigations in payments to physicians.\u003c/p\u003e","\u003cp\u003eRepresented individuals in connection with House and Senate committee inquiries and ethics investigations.\u003c/p\u003e"],"recognitions":[{"title":"Band 1 Top Ranked Lawyer, Government Relations: Congressional Investigations - USA - Nationwide","detail":"Chambers USA, 2021-2024"},{"title":"“[Daniel] provides superb service and is an absolutely indispensable partner. He is incredibly responsive.”","detail":"Chambers USA"},{"title":"Tier 1 Government Relations: Congressional Investigations","detail":"Legal 500 US, 2024"},{"title":"“Life Sciences Star” White-Collar/Govt. Investigations","detail":"LMG Life Sciences, 2024"},{"title":"GIR 100","detail":"Global Investigations Review, 2024"},{"title":"Tier 1 for Government Relations Practice","detail":"Best Lawyers, 2024"},{"title":"“[W]e have complete confidence in his ability to manage complex issues and communicate with our senior leaders.”","detail":"Chambers USA"},{"title":"“King \u0026 Spalding is best known for its impressive congressional investigations practice.”","detail":"Chambers USA, 2008-2024"},{"title":"“Daniel is an expert in Congressional investigations and is always able to keep a calm head”","detail":"Chambers USA, 2021-2024"},{"title":"“Daniel provides extremely good insight into the Congressional process and can convey it to high-level executives.”","detail":"Chambers USA"},{"title":"“[A]ctive in high-profile congressional investigations, and includes ... experts such as Daniel Donovan”","detail":"Legal 500 US"},{"title":"King \u0026 Spalding has “a strong track in congressional investigations … Daniel Donovan is a key contact”","detail":"Legal 500 US"},{"title":"Nationwide Government Relations Practice Ranking","detail":"Chambers USA 2008-2024"},{"title":"Leading Government Relations Lawyer","detail":"Legal 500 US, 2020-2024"},{"title":"Crisis Management and Government Oversight Practice Award","detail":"National Law Journal 2021"},{"title":"“Law Firm of the Year” for Government Relations","detail":"US News \u0026 World Report"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9964}]},"capability_group_id":2},"created_at":"2025-08-14T15:45:04.000Z","updated_at":"2025-08-14T15:45:04.000Z","searchable_text":"Donovan{{ FIELD }}{:title=\u0026gt;\"Band 1 Top Ranked Lawyer, Government Relations: Congressional Investigations - USA - Nationwide\", :detail=\u0026gt;\"Chambers USA, 2021-2024\"}{{ FIELD }}{:title=\u0026gt;\"“[Daniel] provides superb service and is an absolutely indispensable partner. He is incredibly responsive.”\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Tier 1 Government Relations: Congressional Investigations\", :detail=\u0026gt;\"Legal 500 US, 2024\"}{{ FIELD }}{:title=\u0026gt;\"“Life Sciences Star” White-Collar/Govt. Investigations\", :detail=\u0026gt;\"LMG Life Sciences, 2024\"}{{ FIELD }}{:title=\u0026gt;\"GIR 100\", :detail=\u0026gt;\"Global Investigations Review, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Tier 1 for Government Relations Practice\", :detail=\u0026gt;\"Best Lawyers, 2024\"}{{ FIELD }}{:title=\u0026gt;\"“[W]e have complete confidence in his ability to manage complex issues and communicate with our senior leaders.”\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"“King \u0026amp; Spalding is best known for its impressive congressional investigations practice.”\", :detail=\u0026gt;\"Chambers USA, 2008-2024\"}{{ FIELD }}{:title=\u0026gt;\"“Daniel is an expert in Congressional investigations and is always able to keep a calm head”\", :detail=\u0026gt;\"Chambers USA, 2021-2024\"}{{ FIELD }}{:title=\u0026gt;\"“Daniel provides extremely good insight into the Congressional process and can convey it to high-level executives.”\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"“[A]ctive in high-profile congressional investigations, and includes ... experts such as Daniel Donovan”\", :detail=\u0026gt;\"Legal 500 US\"}{{ FIELD }}{:title=\u0026gt;\"King \u0026amp; Spalding has “a strong track in congressional investigations … Daniel Donovan is a key contact”\", :detail=\u0026gt;\"Legal 500 US\"}{{ FIELD }}{:title=\u0026gt;\"Nationwide Government Relations Practice Ranking\", :detail=\u0026gt;\"Chambers USA 2008-2024\"}{{ FIELD }}{:title=\u0026gt;\"Leading Government Relations Lawyer\", :detail=\u0026gt;\"Legal 500 US, 2020-2024\"}{{ FIELD }}{:title=\u0026gt;\"Crisis Management and Government Oversight Practice Award\", :detail=\u0026gt;\"National Law Journal 2021\"}{{ FIELD }}{:title=\u0026gt;\"“Law Firm of the Year” for Government Relations\", :detail=\u0026gt;\"US News \u0026amp; World Report\"}{{ FIELD }}Experience representing numerous clients under investigation by Republican-controlled Senate and House Committees, including Senate Banking, Commerce, Finance, HELP, Homeland Security, Judiciary, Permanent Subcommittee on Investigations, Special Committee on Aging, and House Education and the Workforce, Energy \u0026amp; Commerce, Financial Services, Judiciary, Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, Select Committee on CCP, and Ways \u0026amp; Means, among others.{{ FIELD }}Providing advice and counsel with respect to congressional oversight activity to leading companies in private sector industries, including accounting, auto, banking, consulting, defense, energy, fashion, food, healthcare provider, higher education, insurance, medical device, pharmaceutical, private equity, and tech, among others.{{ FIELD }}Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, cybersecurity breaches, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.{{ FIELD }}Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations.{{ FIELD }}Representing a variety of clients on healthcare policy and legislative issues.{{ FIELD }}Represented a major university and pharmaceutical company in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research.{{ FIELD }}Represented a global financial institution in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters.{{ FIELD }}Represented a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds.{{ FIELD }}Represented multiple pharmaceutical companies in House and Senate investigations related to Affordable Care Act enactment and implementation.{{ FIELD }}Represented medical device companies in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians.{{ FIELD }}Represented a leading clean energy technology company in connection with a Senate investigation into Department of Energy grant program.{{ FIELD }}Represented a major oil company in connection with congressional investigations.{{ FIELD }}Represented a health insurer in House and Senate investigations related to Affordable Care Act implementation.{{ FIELD }}Represented a coalition of food product companies in connection with congressional inquiries relating to food safety and regulatory issues.{{ FIELD }}Represented a medical society in connection with Senate committee investigations in payments to physicians.{{ FIELD }}Represented individuals in connection with House and Senate committee inquiries and ethics investigations.{{ FIELD }}Dan Donovan specializes in congressional, state attorneys general and parallel government investigations. A former Chief Investigative Counsel in the Senate, Dan co-chairs our Government Advocacy and Congressional Investigations practices perennially recognized by Chambers USA: “King \u0026amp; Spalding is best known for its impressive congressional investigations practice, with several dedicated members working exclusively in this area.” Dan is ranked Band 1 for Congressional Investigations by Chambers USA and Tier 1 Legal 500 US.  He has two decades of crisis management experience with government investigations, involving significant legal, public relations and political risks.\nDan represents leading companies, individuals, trade associations, and nonprofit entities and provides effective crisis management counsel. He works at the forefront of controversial and politicized national and state policy issues that frequently lead to investigations and litigation, including congressional, multi-state and federal agency enforcement actions. Particularly experienced in anticipating and responding to congressional committee requests and subpoenas, Dan prepares clients for high-profile hearings and guides them through the unique challenges presented by congressional and parallel government investigations.\nBefore joining the firm, Dan served as Senior Investigative Counsel to Senator Charles Grassley, then Chairman of the Committee on Finance. While serving in the U.S. Senate, Dan managed congressional investigations and oversight hearings. In this role, Dan directed investigations focused on statutory and regulatory compliance, including drug and device safety, drug pricing, and waste, fraud and abuse in Medicare, Medicaid and other government programs. He also handled policy and legislative matters, including the False Claims Act, the Food, Drug, and Cosmetic Act, Medicare and Medicaid programs, and related statutes. Dan also served as Chief Investigative Counsel to the Senate Committee on Small Business, where he managed consumer fraud and small business protection investigations and hearings. He began his congressional career as a Staff Assistant on the Senate Committee on Governmental Affairs, chaired by Senator Fred Thompson, working on the special investigation into the 1996 federal election campaigns.\nDan also provides strategic policy and legislative counsel, and is a frequent speaker on congressional oversight and investigations. Daniel Donovan lawyer Partner Band 1 Top Ranked Lawyer, Government Relations: Congressional Investigations - USA - Nationwide Chambers USA, 2021-2024 “[Daniel] provides superb service and is an absolutely indispensable partner. He is incredibly responsive.” Chambers USA Tier 1 Government Relations: Congressional Investigations Legal 500 US, 2024 “Life Sciences Star” White-Collar/Govt. Investigations LMG Life Sciences, 2024 GIR 100 Global Investigations Review, 2024 Tier 1 for Government Relations Practice Best Lawyers, 2024 “[W]e have complete confidence in his ability to manage complex issues and communicate with our senior leaders.” Chambers USA “King \u0026amp; Spalding is best known for its impressive congressional investigations practice.” Chambers USA, 2008-2024 “Daniel is an expert in Congressional investigations and is always able to keep a calm head” Chambers USA, 2021-2024 “Daniel provides extremely good insight into the Congressional process and can convey it to high-level executives.” Chambers USA “[A]ctive in high-profile congressional investigations, and includes ... experts such as Daniel Donovan” Legal 500 US King \u0026amp; Spalding has “a strong track in congressional investigations … Daniel Donovan is a key contact” Legal 500 US Nationwide Government Relations Practice Ranking Chambers USA 2008-2024 Leading Government Relations Lawyer Legal 500 US, 2020-2024 Crisis Management and Government Oversight Practice Award National Law Journal 2021 “Law Firm of the Year” for Government Relations US News \u0026amp; World Report University of Rochester  American University Washington College of Law District of Columbia Maryland Experience representing numerous clients under investigation by Republican-controlled Senate and House Committees, including Senate Banking, Commerce, Finance, HELP, Homeland Security, Judiciary, Permanent Subcommittee on Investigations, Special Committee on Aging, and House Education and the Workforce, Energy \u0026amp; Commerce, Financial Services, Judiciary, Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, Select Committee on CCP, and Ways \u0026amp; Means, among others. Providing advice and counsel with respect to congressional oversight activity to leading companies in private sector industries, including accounting, auto, banking, consulting, defense, energy, fashion, food, healthcare provider, higher education, insurance, medical device, pharmaceutical, private equity, and tech, among others. Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, cybersecurity breaches, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest. Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations. Representing a variety of clients on healthcare policy and legislative issues. Represented a major university and pharmaceutical company in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research. Represented a global financial institution in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters. Represented a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds. Represented multiple pharmaceutical companies in House and Senate investigations related to Affordable Care Act enactment and implementation. Represented medical device companies in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians. Represented a leading clean energy technology company in connection with a Senate investigation into Department of Energy grant program. Represented a major oil company in connection with congressional investigations. Represented a health insurer in House and Senate investigations related to Affordable Care Act implementation. Represented a coalition of food product companies in connection with congressional inquiries relating to food safety and regulatory issues. Represented a medical society in connection with Senate committee investigations in payments to physicians. Represented individuals in connection with House and Senate committee inquiries and ethics investigations.","searchable_name":"Daniel F. Donovan (Dan)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445382,"version":1,"owner_type":"Person","owner_id":2145,"payload":{"bio":"\u003cp\u003eShane Dornburg focuses on finance and financial transactions. A partner in our Finance practice, Shane represents financial institutions, lenders, investors and borrowers in a variety of specialized financings and transactions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eShane works with clients on leveraged finance transactions, including syndicated credit facilities, acquisition financings, cash flow and asset-based financings, and project financings, with a focus on the healthcare service, healthcare IT, pharmaceutical, medical device, media and telecommunications industries.\u003c/p\u003e\n\u003cp\u003eShane was named a \"Georgia Rising Star\u0026rdquo; by \u003cem\u003eSuper Lawyers Magazine\u003c/em\u003e in 2013 and 2017\u003cem\u003e. S\u003c/em\u003ehane has been Chambers ranked in Banking \u0026amp; Finance every year since 2022\u003c/p\u003e","slug":"shane-dornburg","email":"sdornburg@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eCapital One Healthcare\u003c/strong\u003e as administrative agent in connection with $1.589 billion of senior credit facilities, the proceeds of which were used to fund dividends, acquisitions and foreign expansion for an international pharmaceuticals manufacturing and distribution company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eMidCap Financial Trust\u003c/strong\u003e as administrative agent in connection with $12.0 million of senior credit facilities, the proceeds of which were used to refinance indebtedness and fund ongoing operations for a developer of software-driven medical technologies for the detection of skin cancers. \u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eSunTrust Bank\u003c/strong\u003e as administrative agent in connection with $395 million of senior credit facilities, the proceeds of which were used to fund multiple acquisitions and ongoing operations for an operator of mining and rock quarry facilities and distributor of aggregate products.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major investement firm\u003c/strong\u003e\u0026nbsp;as administrative agent in connection with $10.5 million of senior credit facilities for a global provider of managed infrastructure, global networks, collocation and financial trading solutions.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eGeneral Electric Capital Corporation\u003c/strong\u003e as administrative agent in connection with $170 million of first and second lien senior credit facilities, the proceeds of which were used to refinance indebtedness for a leading national home healthcare provider.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":61}]},"expertise":[{"id":107,"guid":"107.capabilities","index":0,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":734,"guid":"734.smart_tags","index":3,"source":"smartTags"},{"id":75,"guid":"75.capabilities","index":4,"source":"capabilities"},{"id":1179,"guid":"1179.smart_tags","index":5,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":6,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":7,"source":"capabilities"}],"is_active":true,"last_name":"Dornburg","nick_name":"Shane","clerkships":[],"first_name":"Shane","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eShane Dornburg focuses on finance and financial transactions. A partner in our Finance practice, Shane represents financial institutions, lenders, investors and borrowers in a variety of specialized financings and transactions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eShane works with clients on leveraged finance transactions, including syndicated credit facilities, acquisition financings, cash flow and asset-based financings, and project financings, with a focus on the healthcare service, healthcare IT, pharmaceutical, medical device, media and telecommunications industries.\u003c/p\u003e\n\u003cp\u003eShane was named a \"Georgia Rising Star\u0026rdquo; by \u003cem\u003eSuper Lawyers Magazine\u003c/em\u003e in 2013 and 2017\u003cem\u003e. S\u003c/em\u003ehane has been Chambers ranked in Banking \u0026amp; Finance every year since 2022\u003c/p\u003e","matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eCapital One Healthcare\u003c/strong\u003e as administrative agent in connection with $1.589 billion of senior credit facilities, the proceeds of which were used to fund dividends, acquisitions and foreign expansion for an international pharmaceuticals manufacturing and distribution company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eMidCap Financial Trust\u003c/strong\u003e as administrative agent in connection with $12.0 million of senior credit facilities, the proceeds of which were used to refinance indebtedness and fund ongoing operations for a developer of software-driven medical technologies for the detection of skin cancers. \u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eSunTrust Bank\u003c/strong\u003e as administrative agent in connection with $395 million of senior credit facilities, the proceeds of which were used to fund multiple acquisitions and ongoing operations for an operator of mining and rock quarry facilities and distributor of aggregate products.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major investement firm\u003c/strong\u003e\u0026nbsp;as administrative agent in connection with $10.5 million of senior credit facilities for a global provider of managed infrastructure, global networks, collocation and financial trading solutions.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eGeneral Electric Capital Corporation\u003c/strong\u003e as administrative agent in connection with $170 million of first and second lien senior credit facilities, the proceeds of which were used to refinance indebtedness for a leading national home healthcare provider.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13208}]},"capability_group_id":1},"created_at":"2026-01-30T17:30:10.000Z","updated_at":"2026-01-30T17:30:10.000Z","searchable_text":"Dornburg{{ FIELD }}Represented Capital One Healthcare as administrative agent in connection with $1.589 billion of senior credit facilities, the proceeds of which were used to fund dividends, acquisitions and foreign expansion for an international pharmaceuticals manufacturing and distribution company.{{ FIELD }}Represented MidCap Financial Trust as administrative agent in connection with $12.0 million of senior credit facilities, the proceeds of which were used to refinance indebtedness and fund ongoing operations for a developer of software-driven medical technologies for the detection of skin cancers.  {{ FIELD }}Represented SunTrust Bank as administrative agent in connection with $395 million of senior credit facilities, the proceeds of which were used to fund multiple acquisitions and ongoing operations for an operator of mining and rock quarry facilities and distributor of aggregate products.{{ FIELD }}Represented a major investement firm as administrative agent in connection with $10.5 million of senior credit facilities for a global provider of managed infrastructure, global networks, collocation and financial trading solutions.{{ FIELD }}Represented General Electric Capital Corporation as administrative agent in connection with $170 million of first and second lien senior credit facilities, the proceeds of which were used to refinance indebtedness for a leading national home healthcare provider.{{ FIELD }}Shane Dornburg focuses on finance and financial transactions. A partner in our Finance practice, Shane represents financial institutions, lenders, investors and borrowers in a variety of specialized financings and transactions.\nShane works with clients on leveraged finance transactions, including syndicated credit facilities, acquisition financings, cash flow and asset-based financings, and project financings, with a focus on the healthcare service, healthcare IT, pharmaceutical, medical device, media and telecommunications industries.\nShane was named a \"Georgia Rising Star” by Super Lawyers Magazine in 2013 and 2017. Shane has been Chambers ranked in Banking \u0026amp; Finance every year since 2022 Shane Dornburg Partner University of Georgia University of Georgia School of Law Georgia State University Georgia State University College of Law U.S. District Court for the Northern District of Georgia Georgia American Bar Association Atlanta Bar Association Represented Capital One Healthcare as administrative agent in connection with $1.589 billion of senior credit facilities, the proceeds of which were used to fund dividends, acquisitions and foreign expansion for an international pharmaceuticals manufacturing and distribution company. Represented MidCap Financial Trust as administrative agent in connection with $12.0 million of senior credit facilities, the proceeds of which were used to refinance indebtedness and fund ongoing operations for a developer of software-driven medical technologies for the detection of skin cancers.   Represented SunTrust Bank as administrative agent in connection with $395 million of senior credit facilities, the proceeds of which were used to fund multiple acquisitions and ongoing operations for an operator of mining and rock quarry facilities and distributor of aggregate products. Represented a major investement firm as administrative agent in connection with $10.5 million of senior credit facilities for a global provider of managed infrastructure, global networks, collocation and financial trading solutions. Represented General Electric Capital Corporation as administrative agent in connection with $170 million of first and second lien senior credit facilities, the proceeds of which were used to refinance indebtedness for a leading national home healthcare provider.","searchable_name":"Shane Dornburg","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":431968,"version":1,"owner_type":"Person","owner_id":542,"payload":{"bio":"\u003cp\u003eGeoffrey Drake is a partner in our Product Liability \u0026amp; Mass Torts Practice and a member of the firm's\u0026nbsp;Policy Committee.\u0026nbsp;Geoffrey is also Chair of our Consumer Products \u0026amp; Automotive Litigation Team, which \u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;has recognized as one of the top five such practices in the country. Before that, Geoffrey led our Pharmaceutical/Medical Device Litigation Team. Geoffrey represents life sciences,\u0026nbsp;automotive and transportation, technology\u0026nbsp;and energy/mining\u0026nbsp;companies in high-profile product liability, toxic tort\u0026nbsp;and\u0026nbsp;mass tort litigation, for which he has extensive experience litigating all phases of individual, MDL and class action cases, as well as serving as coordinating and strategic counsel in connection with large dockets of cases at the federal and state levels.\u0026nbsp;Clients recently described Geoffrey to \u003cem\u003eChambers USA \u003c/em\u003eas \"extraordinary,\" incredibly talented,\" a \"clear communicator,\" \"very bright,\" \"good on his feet,\" and \"a common-sense litigator.\" In particular, clients compliment Geoffrey's ability to bring \"strategic insight and creativity to the table\" while also doing \"an excellent job imposing order on chaos.\"[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Geoffrey represents clients in nationwide, high-exposure product liability, mass tort, class action, toxic tort and whistleblower litigation, along with internal and government investigations. He litigates all phases of cases in federal and state courts nationwide, including in the most challenging jurisdictions for corporate clients. From the start, Geoffrey handles each matter with a view toward trial, considering how to communicate effectively to a jury a host of complex scientific, technical and regulatory issues. Geoffrey also has significant experience with legal project management, having helped structure, lead\u0026nbsp;and manage several large, cross-practice, cross-office matters, including to design and implement sophisticated budgets and alternative billing arrangements and manage the organization, workflow\u0026nbsp;and staffing plans to deliver the client exceptional and efficient services.\u003c/p\u003e\n\u003cp\u003eGeoffrey chairs our nationally recognized Consumer Products \u0026amp; Automotive Litigation Team. And for five years before that, he chaired our leading Pharmaceutical \u0026amp; Medical Device Litigation Team. He is ranked by \u003cem\u003eChambers USA \u003c/em\u003ein Product Liability\u0026nbsp; (Band Two: Georgia) and has been recommended by\u0026nbsp;\u003cem\u003eLegal 500\u0026nbsp;\u003c/em\u003eas a Key Lawyer in consumer products litigation, automotive litigation\u0026nbsp;and pharmaceutical and medical device litigation for the past several years.\u0026nbsp;In 2025, \u003cem\u003eLawdragon \u003c/em\u003erecognized Geoffrey on its inaugural list of the 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyers. Geoffrey co-authored the leading treatise, \u003cem\u003eDrug and Device Product Liability Litigation Strategy, 2nd Edition\u003c/em\u003e (Oxford Univ. Press). In 2016, \u003cem\u003eLaw360\u003c/em\u003e listed Geoffrey as a \u0026ldquo;Rising Star\u0026rdquo; in product liability litigation, recognizing him as among top legal talent under the age of 40\u003cem\u003e.\u003c/em\u003e He was named to the \u003cem\u003eBenchmark Litigation \u003c/em\u003e\"40 \u0026amp; Under Hot List\u0026rdquo; for five\u0026nbsp;consecutive years, was named by \u003cem\u003eBenchmark Litigation\u0026nbsp;\u003c/em\u003eas a \"Future Star\" in 2018, and was named in 2018 to the \u003cem\u003eDaily Report\u0026rsquo;s \u003c/em\u003e\u0026ldquo;On the Rise\u0026rdquo; list of attorneys under the age of 40 who are expected to go far in the field. Geoffrey also served as a member of the inaugural Next Generation Advisory Board for Emory University's Institute for Complex Litigation and Mass Claims.\u003c/p\u003e\n\u003cp\u003eGeoffrey was elected to a 3-year term on\u0026nbsp;the firm's Policy Committee in December 2024.\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","slug":"geoffrey-drake","email":"gdrake@kslaw.com","phone":"+1 404 824 3277","matters":["\u003cp\u003eLead Counsel to\u0026nbsp;\u003cstrong\u003eTikTok Inc.\u0026nbsp;\u003c/strong\u003ein nationwide litigation in which individual plaintiffs allege personal injuries and school districts and other governmental entities allege economic damages arising from adolescent use of various online communications services, including in the\u0026nbsp;\u003cem\u003eIn re Social Media Adolescent Addiction/Personal Injury Litigation\u0026nbsp;\u003c/em\u003eMDL pending in the Northern District of California and the\u0026nbsp;\u003cem\u003eIn re Social Media Cases\u003c/em\u003e\u0026nbsp;JCCP pending in Los Angeles County.\u003c/p\u003e","\u003cp\u003eLead counsel to\u0026nbsp;\u003cstrong\u003eActivision Blizzard\u003c/strong\u003e\u0026nbsp;in connection with nationwide lawsuits alleging a variety of personal injuries and psychiatric harms arising from addiction to playing video games. In 2024, Geoffrey successfully argued on behalf of more than a dozen game developers and platforms in opposition to a petition to consolidate then-pending lawsuits in a federal MDL.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eRenco Group\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eDoe Run Resources\u003c/strong\u003e\u0026nbsp;in mass tort litigation in two consolidated proceedings in federal court in St. Louis concerning personal-injury allegations by several thousand Peruvians citizens allegedly harmed by exposure to lead and other contaminants from a smelter in the Andean Highlands of Peru.\u003c/p\u003e","\u003cp\u003eCo-Coordinating and Strategic Counsel to a\u0026nbsp;\u003cstrong\u003eU.S. automobile manufacturer\u003c/strong\u003e\u0026nbsp;in connection with thousands of California consumer fraud and breach of warranty lawsuits; previously co-led team representing\u0026nbsp;\u003cstrong\u003eanother U.S. automobile manufacturer\u003c/strong\u003e\u0026nbsp;in hundreds of consumer-fraud lawsuits in California.\u003c/p\u003e","\u003cp\u003eNational Counsel to\u0026nbsp;\u003cstrong\u003eViking Group, Inc.\u0026nbsp;\u003c/strong\u003ewith respect to claims and lawsuits relating to property damage arising from alleged manufacturing or design defects in fire suppression equipment.\u003c/p\u003e","\u003cp\u003eRepresenting a\u0026nbsp;\u003cstrong\u003elarge industrial real estate company\u003c/strong\u003e\u0026nbsp;in connection with hundreds of lawsuits in Georgia state courts alleging cancers and personal injuries, as well as property devaluation, from exposure to ethylene oxide from a lessee's medical-device-sterilization operation.\u003c/p\u003e","\u003cp\u003eServing as one of a core group of partners leading the national coordinating and trial counsel team representing\u0026nbsp;\u003cstrong\u003eGlaxoSmithKline\u003c/strong\u003e\u0026nbsp;in nationwide litigation concerning allegations of suicidality and birth defects from use of the company\u0026rsquo;s antidepressant.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eColoplast\u003c/strong\u003e\u0026nbsp;as part of the team serving as National Coordinating and Trial Counsel in nationwide product liability litigation relating to injuries allegedly caused by the company\u0026rsquo;s female pelvic mesh devices.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eMerck\u003c/strong\u003e\u0026nbsp;in multidistrict litigation (MDL) involving allegations of injuries from use of the company\u0026rsquo;s osteoporosis medication, including in three bellwether trials in two different MDLs. In\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eGlynn v. Merck\u003c/em\u003e, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u003c/strong\u003e\u0026nbsp;in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial; a\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing.\u003c/p\u003e","\u003cp\u003eCo-led several 360-degree risk assessments for a\u0026nbsp;\u003cstrong\u003eleading pharmaceutical manufacturer\u0026nbsp;\u003c/strong\u003ein connection with the launch of new medications.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ehealthcare companies\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eemployers\u0026nbsp;\u003c/strong\u003ein multiple COVID-19-related wrongful death lawsuits.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ePurdue Pharma\u003c/strong\u003e\u0026nbsp;in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company\u0026rsquo;s marketing and promotion of its prescription pain medication.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eDaVita Healthcare Partners\u003c/strong\u003e\u0026nbsp;in a\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;case brought under the federal False Claims Act claiming improper billing of Medicare for unnecessary wastage of two medications used to treat dialysis patients.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ea leading automobile manufacturer\u003c/strong\u003e\u0026nbsp;in connection with government investigations and multi-jurisdictional civil litigation relating to a series of high-profile vehicle recalls.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eowner of petroleum pipeline terminals\u003c/strong\u003e\u0026nbsp;in federal MDL proceedings in an action filed by the Pennsylvania Attorney General involving claims of groundwater contamination from MTBE-containing gasoline.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eLincoln Electric Company\u003c/strong\u003e\u0026nbsp;and other manufacturers in cases involving claims from exposure to manganese fumes from welding rods, and serving as national discovery counsel in the litigation for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eEutectic Corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eCooper Industries\u003c/strong\u003e, the successor of a former operator of a Superfund site, in litigation involving allegations of a variety of personal injuries from PCB exposure.\u003c/p\u003e","\u003cdiv id=\"mySiteMain\" data-name=\"ContentPlaceHolderMain\"\u003e\n\u003cdiv id=\"ctl00_PageContentSection\" class=\"pageContentSection\"\u003e\n\u003cdiv class=\"fixedWidthMain\"\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ePhillips Services Corp.\u003c/strong\u003e\u0026nbsp;in a class action lawsuit involving nuisance allegations arising from the release of odors from a wastewater treatment facility.\u003cbr /\u003e\n\u003cdiv class=\"clear\"\u003e\u0026nbsp;\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003cdiv class=\"pageFooterSection noindex\"\u003e\u0026nbsp;\u003c/div\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3271}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":5,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":6,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":7,"source":"smartTags"},{"id":762,"guid":"762.smart_tags","index":8,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":9,"source":"capabilities"},{"id":1256,"guid":"1256.smart_tags","index":10,"source":"smartTags"},{"id":118,"guid":"118.capabilities","index":11,"source":"capabilities"}],"is_active":true,"last_name":"Drake","nick_name":"Geoffrey","clerkships":[],"first_name":"Geoffrey","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: consumer products","detail":"Legal 500, 2024"},{"title":"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: pharmaceuticals and medical devices","detail":"Legal 500, 2020-2024"},{"title":"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: automotive","detail":"Legal 500, 2023-2024"},{"title":"Recommended/Key Lawyer in Rail And Road - Litigation and Regulation","detail":"Legal 500, 2024"},{"title":"500 Leading Global Entertainment, Sports \u0026 Media Lawyers ","detail":"Lawdragon, 2025"},{"title":"Named to Best Lawyers in America, Commercial Litigation","detail":"2023 -2025"},{"title":"Named to \"On the Rise\" list","detail":"Daily Report, 2018"},{"title":"Named to Product Liability Editorial Advisory Board","detail":"Law360, 2018"},{"title":"Named Future Star","detail":"Benchmark Litigation, 2018"},{"title":"Named to Under 40 Hot List","detail":"Benchmark Litigation, 2016-2020"},{"title":"Named a Rising Star in Product Liability Litigation","detail":"Law360, 2016"},{"title":"Appointed to Next Generation Advisory Board","detail":"Emory University's Institute for Complex Litigation and Mass Claims, 2016"},{"title":"Named a Georgia Super Lawyer - Rising Star","detail":"Super Lawyers and Atlanta Magazine, 2013–2020"},{"title":"Graduate of the International Association of Defense Counsel’s Trial Academy","detail":"2012"},{"title":"Order of the Coif","detail":"Vanderbilt University Law School, 2005"},{"title":"Best Oralist Award","detail":"Vanderbilt University Law School Intramural Moot Coot Competition, 2004"},{"title":"Executive Development Editor","detail":"Vanderbilt Journal of Transnational Law, 2005"}],"linked_in_url":"https://www.linkedin.com/in/geoffrey-drake-11504574/","seodescription":"Geoffrey Drake is a lawyer of the Product Liability \u0026 Mass Torts Practice. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eGeoffrey Drake is a partner in our Product Liability \u0026amp; Mass Torts Practice and a member of the firm's\u0026nbsp;Policy Committee.\u0026nbsp;Geoffrey is also Chair of our Consumer Products \u0026amp; Automotive Litigation Team, which \u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;has recognized as one of the top five such practices in the country. Before that, Geoffrey led our Pharmaceutical/Medical Device Litigation Team. Geoffrey represents life sciences,\u0026nbsp;automotive and transportation, technology\u0026nbsp;and energy/mining\u0026nbsp;companies in high-profile product liability, toxic tort\u0026nbsp;and\u0026nbsp;mass tort litigation, for which he has extensive experience litigating all phases of individual, MDL and class action cases, as well as serving as coordinating and strategic counsel in connection with large dockets of cases at the federal and state levels.\u0026nbsp;Clients recently described Geoffrey to \u003cem\u003eChambers USA \u003c/em\u003eas \"extraordinary,\" incredibly talented,\" a \"clear communicator,\" \"very bright,\" \"good on his feet,\" and \"a common-sense litigator.\" In particular, clients compliment Geoffrey's ability to bring \"strategic insight and creativity to the table\" while also doing \"an excellent job imposing order on chaos.\"[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Geoffrey represents clients in nationwide, high-exposure product liability, mass tort, class action, toxic tort and whistleblower litigation, along with internal and government investigations. He litigates all phases of cases in federal and state courts nationwide, including in the most challenging jurisdictions for corporate clients. From the start, Geoffrey handles each matter with a view toward trial, considering how to communicate effectively to a jury a host of complex scientific, technical and regulatory issues. Geoffrey also has significant experience with legal project management, having helped structure, lead\u0026nbsp;and manage several large, cross-practice, cross-office matters, including to design and implement sophisticated budgets and alternative billing arrangements and manage the organization, workflow\u0026nbsp;and staffing plans to deliver the client exceptional and efficient services.\u003c/p\u003e\n\u003cp\u003eGeoffrey chairs our nationally recognized Consumer Products \u0026amp; Automotive Litigation Team. And for five years before that, he chaired our leading Pharmaceutical \u0026amp; Medical Device Litigation Team. He is ranked by \u003cem\u003eChambers USA \u003c/em\u003ein Product Liability\u0026nbsp; (Band Two: Georgia) and has been recommended by\u0026nbsp;\u003cem\u003eLegal 500\u0026nbsp;\u003c/em\u003eas a Key Lawyer in consumer products litigation, automotive litigation\u0026nbsp;and pharmaceutical and medical device litigation for the past several years.\u0026nbsp;In 2025, \u003cem\u003eLawdragon \u003c/em\u003erecognized Geoffrey on its inaugural list of the 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyers. Geoffrey co-authored the leading treatise, \u003cem\u003eDrug and Device Product Liability Litigation Strategy, 2nd Edition\u003c/em\u003e (Oxford Univ. Press). In 2016, \u003cem\u003eLaw360\u003c/em\u003e listed Geoffrey as a \u0026ldquo;Rising Star\u0026rdquo; in product liability litigation, recognizing him as among top legal talent under the age of 40\u003cem\u003e.\u003c/em\u003e He was named to the \u003cem\u003eBenchmark Litigation \u003c/em\u003e\"40 \u0026amp; Under Hot List\u0026rdquo; for five\u0026nbsp;consecutive years, was named by \u003cem\u003eBenchmark Litigation\u0026nbsp;\u003c/em\u003eas a \"Future Star\" in 2018, and was named in 2018 to the \u003cem\u003eDaily Report\u0026rsquo;s \u003c/em\u003e\u0026ldquo;On the Rise\u0026rdquo; list of attorneys under the age of 40 who are expected to go far in the field. Geoffrey also served as a member of the inaugural Next Generation Advisory Board for Emory University's Institute for Complex Litigation and Mass Claims.\u003c/p\u003e\n\u003cp\u003eGeoffrey was elected to a 3-year term on\u0026nbsp;the firm's Policy Committee in December 2024.\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","matters":["\u003cp\u003eLead Counsel to\u0026nbsp;\u003cstrong\u003eTikTok Inc.\u0026nbsp;\u003c/strong\u003ein nationwide litigation in which individual plaintiffs allege personal injuries and school districts and other governmental entities allege economic damages arising from adolescent use of various online communications services, including in the\u0026nbsp;\u003cem\u003eIn re Social Media Adolescent Addiction/Personal Injury Litigation\u0026nbsp;\u003c/em\u003eMDL pending in the Northern District of California and the\u0026nbsp;\u003cem\u003eIn re Social Media Cases\u003c/em\u003e\u0026nbsp;JCCP pending in Los Angeles County.\u003c/p\u003e","\u003cp\u003eLead counsel to\u0026nbsp;\u003cstrong\u003eActivision Blizzard\u003c/strong\u003e\u0026nbsp;in connection with nationwide lawsuits alleging a variety of personal injuries and psychiatric harms arising from addiction to playing video games. In 2024, Geoffrey successfully argued on behalf of more than a dozen game developers and platforms in opposition to a petition to consolidate then-pending lawsuits in a federal MDL.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eRenco Group\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eDoe Run Resources\u003c/strong\u003e\u0026nbsp;in mass tort litigation in two consolidated proceedings in federal court in St. Louis concerning personal-injury allegations by several thousand Peruvians citizens allegedly harmed by exposure to lead and other contaminants from a smelter in the Andean Highlands of Peru.\u003c/p\u003e","\u003cp\u003eCo-Coordinating and Strategic Counsel to a\u0026nbsp;\u003cstrong\u003eU.S. automobile manufacturer\u003c/strong\u003e\u0026nbsp;in connection with thousands of California consumer fraud and breach of warranty lawsuits; previously co-led team representing\u0026nbsp;\u003cstrong\u003eanother U.S. automobile manufacturer\u003c/strong\u003e\u0026nbsp;in hundreds of consumer-fraud lawsuits in California.\u003c/p\u003e","\u003cp\u003eNational Counsel to\u0026nbsp;\u003cstrong\u003eViking Group, Inc.\u0026nbsp;\u003c/strong\u003ewith respect to claims and lawsuits relating to property damage arising from alleged manufacturing or design defects in fire suppression equipment.\u003c/p\u003e","\u003cp\u003eRepresenting a\u0026nbsp;\u003cstrong\u003elarge industrial real estate company\u003c/strong\u003e\u0026nbsp;in connection with hundreds of lawsuits in Georgia state courts alleging cancers and personal injuries, as well as property devaluation, from exposure to ethylene oxide from a lessee's medical-device-sterilization operation.\u003c/p\u003e","\u003cp\u003eServing as one of a core group of partners leading the national coordinating and trial counsel team representing\u0026nbsp;\u003cstrong\u003eGlaxoSmithKline\u003c/strong\u003e\u0026nbsp;in nationwide litigation concerning allegations of suicidality and birth defects from use of the company\u0026rsquo;s antidepressant.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eColoplast\u003c/strong\u003e\u0026nbsp;as part of the team serving as National Coordinating and Trial Counsel in nationwide product liability litigation relating to injuries allegedly caused by the company\u0026rsquo;s female pelvic mesh devices.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eMerck\u003c/strong\u003e\u0026nbsp;in multidistrict litigation (MDL) involving allegations of injuries from use of the company\u0026rsquo;s osteoporosis medication, including in three bellwether trials in two different MDLs. In\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eGlynn v. Merck\u003c/em\u003e, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u003c/strong\u003e\u0026nbsp;in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial; a\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing.\u003c/p\u003e","\u003cp\u003eCo-led several 360-degree risk assessments for a\u0026nbsp;\u003cstrong\u003eleading pharmaceutical manufacturer\u0026nbsp;\u003c/strong\u003ein connection with the launch of new medications.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ehealthcare companies\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eemployers\u0026nbsp;\u003c/strong\u003ein multiple COVID-19-related wrongful death lawsuits.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ePurdue Pharma\u003c/strong\u003e\u0026nbsp;in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company\u0026rsquo;s marketing and promotion of its prescription pain medication.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eDaVita Healthcare Partners\u003c/strong\u003e\u0026nbsp;in a\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;case brought under the federal False Claims Act claiming improper billing of Medicare for unnecessary wastage of two medications used to treat dialysis patients.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ea leading automobile manufacturer\u003c/strong\u003e\u0026nbsp;in connection with government investigations and multi-jurisdictional civil litigation relating to a series of high-profile vehicle recalls.\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eowner of petroleum pipeline terminals\u003c/strong\u003e\u0026nbsp;in federal MDL proceedings in an action filed by the Pennsylvania Attorney General involving claims of groundwater contamination from MTBE-containing gasoline.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eLincoln Electric Company\u003c/strong\u003e\u0026nbsp;and other manufacturers in cases involving claims from exposure to manganese fumes from welding rods, and serving as national discovery counsel in the litigation for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eEutectic Corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eCooper Industries\u003c/strong\u003e, the successor of a former operator of a Superfund site, in litigation involving allegations of a variety of personal injuries from PCB exposure.\u003c/p\u003e","\u003cdiv id=\"mySiteMain\" data-name=\"ContentPlaceHolderMain\"\u003e\n\u003cdiv id=\"ctl00_PageContentSection\" class=\"pageContentSection\"\u003e\n\u003cdiv class=\"fixedWidthMain\"\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ePhillips Services Corp.\u003c/strong\u003e\u0026nbsp;in a class action lawsuit involving nuisance allegations arising from the release of odors from a wastewater treatment facility.\u003cbr /\u003e\n\u003cdiv class=\"clear\"\u003e\u0026nbsp;\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003cdiv class=\"pageFooterSection noindex\"\u003e\u0026nbsp;\u003c/div\u003e"],"recognitions":[{"title":"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: consumer products","detail":"Legal 500, 2024"},{"title":"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: pharmaceuticals and medical devices","detail":"Legal 500, 2020-2024"},{"title":"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: automotive","detail":"Legal 500, 2023-2024"},{"title":"Recommended/Key Lawyer in Rail And Road - Litigation and Regulation","detail":"Legal 500, 2024"},{"title":"500 Leading Global Entertainment, Sports \u0026 Media Lawyers ","detail":"Lawdragon, 2025"},{"title":"Named to Best Lawyers in America, Commercial Litigation","detail":"2023 -2025"},{"title":"Named to \"On the Rise\" list","detail":"Daily Report, 2018"},{"title":"Named to Product Liability Editorial Advisory Board","detail":"Law360, 2018"},{"title":"Named Future Star","detail":"Benchmark Litigation, 2018"},{"title":"Named to Under 40 Hot List","detail":"Benchmark Litigation, 2016-2020"},{"title":"Named a Rising Star in Product Liability Litigation","detail":"Law360, 2016"},{"title":"Appointed to Next Generation Advisory Board","detail":"Emory University's Institute for Complex Litigation and Mass Claims, 2016"},{"title":"Named a Georgia Super Lawyer - Rising Star","detail":"Super Lawyers and Atlanta Magazine, 2013–2020"},{"title":"Graduate of the International Association of Defense Counsel’s Trial Academy","detail":"2012"},{"title":"Order of the Coif","detail":"Vanderbilt University Law School, 2005"},{"title":"Best Oralist Award","detail":"Vanderbilt University Law School Intramural Moot Coot Competition, 2004"},{"title":"Executive Development Editor","detail":"Vanderbilt Journal of Transnational Law, 2005"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11790}]},"capability_group_id":3},"created_at":"2025-07-14T18:55:33.000Z","updated_at":"2025-07-14T18:55:33.000Z","searchable_text":"Drake{{ FIELD }}{:title=\u0026gt;\"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: consumer products\", :detail=\u0026gt;\"Legal 500, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: pharmaceuticals and medical devices\", :detail=\u0026gt;\"Legal 500, 2020-2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended/Key Lawyer in Product liability, mass tort and class action - defense: automotive\", :detail=\u0026gt;\"Legal 500, 2023-2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended/Key Lawyer in Rail And Road - Litigation and Regulation\", :detail=\u0026gt;\"Legal 500, 2024\"}{{ FIELD }}{:title=\u0026gt;\"500 Leading Global Entertainment, Sports \u0026amp; Media Lawyers \", :detail=\u0026gt;\"Lawdragon, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Named to Best Lawyers in America, Commercial Litigation\", :detail=\u0026gt;\"2023 -2025\"}{{ FIELD }}{:title=\u0026gt;\"Named to \\\"On the Rise\\\" list\", :detail=\u0026gt;\"Daily Report, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Named to Product Liability Editorial Advisory Board\", :detail=\u0026gt;\"Law360, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Named Future Star\", :detail=\u0026gt;\"Benchmark Litigation, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Named to Under 40 Hot List\", :detail=\u0026gt;\"Benchmark Litigation, 2016-2020\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Product Liability Litigation\", :detail=\u0026gt;\"Law360, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Appointed to Next Generation Advisory Board\", :detail=\u0026gt;\"Emory University's Institute for Complex Litigation and Mass Claims, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Named a Georgia Super Lawyer - Rising Star\", :detail=\u0026gt;\"Super Lawyers and Atlanta Magazine, 2013–2020\"}{{ FIELD }}{:title=\u0026gt;\"Graduate of the International Association of Defense Counsel’s Trial Academy\", :detail=\u0026gt;\"2012\"}{{ FIELD }}{:title=\u0026gt;\"Order of the Coif\", :detail=\u0026gt;\"Vanderbilt University Law School, 2005\"}{{ FIELD }}{:title=\u0026gt;\"Best Oralist Award\", :detail=\u0026gt;\"Vanderbilt University Law School Intramural Moot Coot Competition, 2004\"}{{ FIELD }}{:title=\u0026gt;\"Executive Development Editor\", :detail=\u0026gt;\"Vanderbilt Journal of Transnational Law, 2005\"}{{ FIELD }}Lead Counsel to TikTok Inc. in nationwide litigation in which individual plaintiffs allege personal injuries and school districts and other governmental entities allege economic damages arising from adolescent use of various online communications services, including in the In re Social Media Adolescent Addiction/Personal Injury Litigation MDL pending in the Northern District of California and the In re Social Media Cases JCCP pending in Los Angeles County.{{ FIELD }}Lead counsel to Activision Blizzard in connection with nationwide lawsuits alleging a variety of personal injuries and psychiatric harms arising from addiction to playing video games. In 2024, Geoffrey successfully argued on behalf of more than a dozen game developers and platforms in opposition to a petition to consolidate then-pending lawsuits in a federal MDL.{{ FIELD }}Representing Renco Group and Doe Run Resources in mass tort litigation in two consolidated proceedings in federal court in St. Louis concerning personal-injury allegations by several thousand Peruvians citizens allegedly harmed by exposure to lead and other contaminants from a smelter in the Andean Highlands of Peru.{{ FIELD }}Co-Coordinating and Strategic Counsel to a U.S. automobile manufacturer in connection with thousands of California consumer fraud and breach of warranty lawsuits; previously co-led team representing another U.S. automobile manufacturer in hundreds of consumer-fraud lawsuits in California.{{ FIELD }}National Counsel to Viking Group, Inc. with respect to claims and lawsuits relating to property damage arising from alleged manufacturing or design defects in fire suppression equipment.{{ FIELD }}Representing a large industrial real estate company in connection with hundreds of lawsuits in Georgia state courts alleging cancers and personal injuries, as well as property devaluation, from exposure to ethylene oxide from a lessee's medical-device-sterilization operation.{{ FIELD }}Serving as one of a core group of partners leading the national coordinating and trial counsel team representing GlaxoSmithKline in nationwide litigation concerning allegations of suicidality and birth defects from use of the company’s antidepressant.{{ FIELD }}Representing Coloplast as part of the team serving as National Coordinating and Trial Counsel in nationwide product liability litigation relating to injuries allegedly caused by the company’s female pelvic mesh devices.{{ FIELD }}Represented Merck in multidistrict litigation (MDL) involving allegations of injuries from use of the company’s osteoporosis medication, including in three bellwether trials in two different MDLs. In Glynn v. Merck, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.{{ FIELD }}Represented the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing.{{ FIELD }}Co-led several 360-degree risk assessments for a leading pharmaceutical manufacturer in connection with the launch of new medications.{{ FIELD }}Representing healthcare companies and employers in multiple COVID-19-related wrongful death lawsuits.{{ FIELD }}Represented Purdue Pharma in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company’s marketing and promotion of its prescription pain medication.{{ FIELD }}Represented DaVita Healthcare Partners in a qui tam case brought under the federal False Claims Act claiming improper billing of Medicare for unnecessary wastage of two medications used to treat dialysis patients.{{ FIELD }}Represented a leading automobile manufacturer in connection with government investigations and multi-jurisdictional civil litigation relating to a series of high-profile vehicle recalls.{{ FIELD }}Represented the owner of petroleum pipeline terminals in federal MDL proceedings in an action filed by the Pennsylvania Attorney General involving claims of groundwater contamination from MTBE-containing gasoline.{{ FIELD }}Represented Lincoln Electric Company and other manufacturers in cases involving claims from exposure to manganese fumes from welding rods, and serving as national discovery counsel in the litigation for Eutectic Corporation.{{ FIELD }}Represented Cooper Industries, the successor of a former operator of a Superfund site, in litigation involving allegations of a variety of personal injuries from PCB exposure.{{ FIELD }}\n\nRepresented Phillips Services Corp. in a class action lawsuit involving nuisance allegations arising from the release of odors from a wastewater treatment facility.\n \n\n\n\n {{ FIELD }}Geoffrey Drake is a partner in our Product Liability \u0026amp; Mass Torts Practice and a member of the firm's Policy Committee. Geoffrey is also Chair of our Consumer Products \u0026amp; Automotive Litigation Team, which Legal 500 has recognized as one of the top five such practices in the country. Before that, Geoffrey led our Pharmaceutical/Medical Device Litigation Team. Geoffrey represents life sciences, automotive and transportation, technology and energy/mining companies in high-profile product liability, toxic tort and mass tort litigation, for which he has extensive experience litigating all phases of individual, MDL and class action cases, as well as serving as coordinating and strategic counsel in connection with large dockets of cases at the federal and state levels. Clients recently described Geoffrey to Chambers USA as \"extraordinary,\" incredibly talented,\" a \"clear communicator,\" \"very bright,\" \"good on his feet,\" and \"a common-sense litigator.\" In particular, clients compliment Geoffrey's ability to bring \"strategic insight and creativity to the table\" while also doing \"an excellent job imposing order on chaos.\"\nAn experienced litigator, Geoffrey represents clients in nationwide, high-exposure product liability, mass tort, class action, toxic tort and whistleblower litigation, along with internal and government investigations. He litigates all phases of cases in federal and state courts nationwide, including in the most challenging jurisdictions for corporate clients. From the start, Geoffrey handles each matter with a view toward trial, considering how to communicate effectively to a jury a host of complex scientific, technical and regulatory issues. Geoffrey also has significant experience with legal project management, having helped structure, lead and manage several large, cross-practice, cross-office matters, including to design and implement sophisticated budgets and alternative billing arrangements and manage the organization, workflow and staffing plans to deliver the client exceptional and efficient services.\nGeoffrey chairs our nationally recognized Consumer Products \u0026amp; Automotive Litigation Team. And for five years before that, he chaired our leading Pharmaceutical \u0026amp; Medical Device Litigation Team. He is ranked by Chambers USA in Product Liability  (Band Two: Georgia) and has been recommended by Legal 500 as a Key Lawyer in consumer products litigation, automotive litigation and pharmaceutical and medical device litigation for the past several years. In 2025, Lawdragon recognized Geoffrey on its inaugural list of the 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyers. Geoffrey co-authored the leading treatise, Drug and Device Product Liability Litigation Strategy, 2nd Edition (Oxford Univ. Press). In 2016, Law360 listed Geoffrey as a “Rising Star” in product liability litigation, recognizing him as among top legal talent under the age of 40. He was named to the Benchmark Litigation \"40 \u0026amp; Under Hot List” for five consecutive years, was named by Benchmark Litigation as a \"Future Star\" in 2018, and was named in 2018 to the Daily Report’s “On the Rise” list of attorneys under the age of 40 who are expected to go far in the field. Geoffrey also served as a member of the inaugural Next Generation Advisory Board for Emory University's Institute for Complex Litigation and Mass Claims.\nGeoffrey was elected to a 3-year term on the firm's Policy Committee in December 2024.\n Geoffrey Drake lawyer Partner Recommended/Key Lawyer in Product liability, mass tort and class action - defense: consumer products Legal 500, 2024 Recommended/Key Lawyer in Product liability, mass tort and class action - defense: pharmaceuticals and medical devices Legal 500, 2020-2024 Recommended/Key Lawyer in Product liability, mass tort and class action - defense: automotive Legal 500, 2023-2024 Recommended/Key Lawyer in Rail And Road - Litigation and Regulation Legal 500, 2024 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyers  Lawdragon, 2025 Named to Best Lawyers in America, Commercial Litigation 2023 -2025 Named to \"On the Rise\" list Daily Report, 2018 Named to Product Liability Editorial Advisory Board Law360, 2018 Named Future Star Benchmark Litigation, 2018 Named to Under 40 Hot List Benchmark Litigation, 2016-2020 Named a Rising Star in Product Liability Litigation Law360, 2016 Appointed to Next Generation Advisory Board Emory University's Institute for Complex Litigation and Mass Claims, 2016 Named a Georgia Super Lawyer - Rising Star Super Lawyers and Atlanta Magazine, 2013–2020 Graduate of the International Association of Defense Counsel’s Trial Academy 2012 Order of the Coif Vanderbilt University Law School, 2005 Best Oralist Award Vanderbilt University Law School Intramural Moot Coot Competition, 2004 Executive Development Editor Vanderbilt Journal of Transnational Law, 2005 University of Virginia University of Virginia School of Law Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Third Circuit U.S. Court of Appeals for the Tenth Circuit U.S. District Court for the Eastern District of Wisconsin U.S. District Court for the Northern District of Georgia Georgia Court of Appeals of Georgia Supreme Court of Georgia Lead Counsel to TikTok Inc. in nationwide litigation in which individual plaintiffs allege personal injuries and school districts and other governmental entities allege economic damages arising from adolescent use of various online communications services, including in the In re Social Media Adolescent Addiction/Personal Injury Litigation MDL pending in the Northern District of California and the In re Social Media Cases JCCP pending in Los Angeles County. Lead counsel to Activision Blizzard in connection with nationwide lawsuits alleging a variety of personal injuries and psychiatric harms arising from addiction to playing video games. In 2024, Geoffrey successfully argued on behalf of more than a dozen game developers and platforms in opposition to a petition to consolidate then-pending lawsuits in a federal MDL. Representing Renco Group and Doe Run Resources in mass tort litigation in two consolidated proceedings in federal court in St. Louis concerning personal-injury allegations by several thousand Peruvians citizens allegedly harmed by exposure to lead and other contaminants from a smelter in the Andean Highlands of Peru. Co-Coordinating and Strategic Counsel to a U.S. automobile manufacturer in connection with thousands of California consumer fraud and breach of warranty lawsuits; previously co-led team representing another U.S. automobile manufacturer in hundreds of consumer-fraud lawsuits in California. National Counsel to Viking Group, Inc. with respect to claims and lawsuits relating to property damage arising from alleged manufacturing or design defects in fire suppression equipment. Representing a large industrial real estate company in connection with hundreds of lawsuits in Georgia state courts alleging cancers and personal injuries, as well as property devaluation, from exposure to ethylene oxide from a lessee's medical-device-sterilization operation. Serving as one of a core group of partners leading the national coordinating and trial counsel team representing GlaxoSmithKline in nationwide litigation concerning allegations of suicidality and birth defects from use of the company’s antidepressant. Representing Coloplast as part of the team serving as National Coordinating and Trial Counsel in nationwide product liability litigation relating to injuries allegedly caused by the company’s female pelvic mesh devices. Represented Merck in multidistrict litigation (MDL) involving allegations of injuries from use of the company’s osteoporosis medication, including in three bellwether trials in two different MDLs. In Glynn v. Merck, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption. Represented the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Co-led several 360-degree risk assessments for a leading pharmaceutical manufacturer in connection with the launch of new medications. Representing healthcare companies and employers in multiple COVID-19-related wrongful death lawsuits. Represented Purdue Pharma in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company’s marketing and promotion of its prescription pain medication. Represented DaVita Healthcare Partners in a qui tam case brought under the federal False Claims Act claiming improper billing of Medicare for unnecessary wastage of two medications used to treat dialysis patients. Represented a leading automobile manufacturer in connection with government investigations and multi-jurisdictional civil litigation relating to a series of high-profile vehicle recalls. Represented the owner of petroleum pipeline terminals in federal MDL proceedings in an action filed by the Pennsylvania Attorney General involving claims of groundwater contamination from MTBE-containing gasoline. Represented Lincoln Electric Company and other manufacturers in cases involving claims from exposure to manganese fumes from welding rods, and serving as national discovery counsel in the litigation for Eutectic Corporation. Represented Cooper Industries, the successor of a former operator of a Superfund site, in litigation involving allegations of a variety of personal injuries from PCB exposure. \n\nRepresented Phillips Services Corp. in a class action lawsuit involving nuisance allegations arising from the release of odors from a wastewater treatment facility.\n \n\n\n\n ","searchable_name":"Geoffrey M. Drake","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445272,"version":1,"owner_type":"Person","owner_id":2349,"payload":{"bio":"\u003cp\u003eJeff Dutson is a restructuring\u0026nbsp;partner in King \u0026amp; Spalding's Leveraged Finance \u0026amp; Restructuring practice group. Jeff\u0026nbsp;represents corporate debtors in Chapter 11 bankruptcy cases throughout the country as well as buyers and sellers in distressed M\u0026amp;A transactions. Jeff also represents\u0026nbsp;banks and other investors in connection with their most complex restructurings, bankruptcy, and finance\u0026nbsp;matters. Jeff\u0026rsquo;s practice spans a wide variety of industries, including the restaurant, real estate, healthcare, energy, transportation, manufacturing, and aviation\u0026nbsp;industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff has been\u0026nbsp;recognized for his work in Bankruptcy and Restructuring by \u003cem\u003eChambers USA \u003c/em\u003eeach year since 2020. In 2021, Jeff was recognized by the American Bankruptcy Institute as part of its 40 Under 40 list of emerging leaders in the insolvency industry. Jeff\u0026nbsp;currently serves as the Co-Chair for\u0026nbsp;the Advisory Board of the American Bankruptcy Institute Southeastern Workshop.\u0026nbsp;He\u0026nbsp;is a fellow of\u0026nbsp;the American College of Investment Counsel and serves on the Board of Trustees for the college.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eOriginally from Atlanta, Georgia, Jeff is a graduate of the\u0026nbsp;University of Chicago (where he earned his law degree, with honors) and the University of Georgia (where he earned his bachelor's degree, with honors).\u0026nbsp;Prior to joining the firm, Jeff served as a law clerk for the Honorable E. Grady Jolly of the U.S. Court of Appeals for the Fifth Circuit.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSelected Publications\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eUnitranche Credit Facilities and the LSTA New Form AAL\u003c/em\u003e, American Bankruptcy Institute Journal, May 2019, with Sarah R. Borders and Jeffrey Misher.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eFifth Circuit Denies Post-Petition Default Interest to Fully Secured Creditors\u003c/em\u003e, The Banking Law Journal, September 2019, with Sarah Primrose and Nadia Saleem.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eOrder's Up!: Navigating Complex Restaurant Restructurings\u003c/em\u003e, American Bankruptcy Institute Journal, July 2018, with Sarah R. Borders.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eWhen Cash Might Not be King: Acquiring Nonprofit Hospitals in Bankruptcy, \u003c/em\u003eAmerican Bankruptcy Institute Journal, September 2017, with Paul K. Ferdinands.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eGoing Once, Going Twice, Sold! (Maybe): Reopening Auctions\u003c/em\u003e, American Bankruptcy Institute Journal, February 2014, with W. Austin Jowers.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eSuccessor Liability under the FLSA: Buyers of Distressed Companies Beware\u003c/em\u003e, American Bankruptcy Institute Journal, June 2013, with Paul K. Ferdinands.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026ldquo;Unfinished Business\" after Geron and Coudert\u003c/em\u003e \u003cem\u003eBrothers\u003c/em\u003e, Dow Jones Daily Bankruptcy Review, September 11, 2012, with Mark M. Maloney.\u003c/p\u003e","slug":"jeffrey-dutson","email":"jdutson@kslaw.com","phone":null,"matters":["\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eRed Lobster\u003c/strong\u003e\u0026nbsp;in its Chapter 11 bankruptcy proceedings in the Middle District of Florida.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eOn The Border\u003c/strong\u003e, a national restaurant chain, in its Chapter 11 bankruptcy proceedings.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eDCL Corporation\u003c/strong\u003e, a global pigments manufacturer, in its Chapter 11 bankruptcy proceedings in the District of Delaware and Canada.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eIgnite Restaurant Group, Inc.\u003c/strong\u003e, and its affiliate\u0026nbsp;\u003cstrong\u003eJoe's Crab Shack\u003c/strong\u003e, in their Chapter 11 bankruptcy proceedings in the Southern District of Texas.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eThe Krystal Company\u003c/strong\u003e, and its affiliates, in their Chapter 11 bankruptcy proceedings in the Northern District of Georgia.\u003c/p\u003e","\u003cp\u003eServed as Debtor\u0026rsquo;s counsel to\u0026nbsp;\u003cstrong\u003eAstroTurf, LLC\u003c/strong\u003e\u0026nbsp;in its Chapter 11 bankruptcy case and sale of its business.\u003c/p\u003e","\u003cp\u003eServed as Debtors\u0026rsquo; counsel to\u0026nbsp;\u003cstrong\u003eCagle\u0026rsquo;s, Inc.\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eCagle\u0026rsquo;s Farms, Inc.\u0026nbsp;\u003c/strong\u003ein their Chapter 11 bankruptcy cases and sale of their businesses. King \u0026amp; Spalding was recognized in connection with the Cagle\u0026rsquo;s transaction, which was named 2013 National Transaction of the Year (Large Company Category) by the international Turnaround Management Association.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eWells Fargo Bank, N.A.\u0026nbsp;\u003c/strong\u003eas Administrative Agent and Lender in the Chapter 11 bankruptcy case of Premier Kings, Inc., a large operator of Burger King franchises, in the Northern District of Alabama\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eGeorgia's Own Credit Union\u0026nbsp;\u003c/strong\u003eas Lender and DIP Lender in the Chapter 11 bankruptcy case of Ryze Renewables, LLC in the District of Delaware\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eTruist Bank\u003c/strong\u003e\u0026nbsp;(successor to SunTrust Bank) and\u0026nbsp;\u003cstrong\u003eSunTrust Equipment Finance \u0026amp; Leasing\u003c/strong\u003e\u0026nbsp;in\u0026nbsp;\u003cem\u003eSunTrust Equipment Finance \u0026amp; Leasing v. International Speedway Corporation\u003c/em\u003e\u0026nbsp;(M.D. Fla.).\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eThe Prudential Insurance Company of America\u003c/strong\u003e, as senior secured noteholder, in connection with the Chapter 11 bankruptcy case of The Legal Coverage Group (E.D. Penn.).\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCitizens Bank\u003c/strong\u003e, as secured lender, in connection with the pre-petition restructuring and Chapter 11 case of Schramm, Inc. (D. Del.), a manufacturer and supplier of branded land-based hydraulic drilling equipment.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCitizens Bank\u003c/strong\u003e, as administrative agent for senior secured lenders, in out-of-court restructuring of large mechanical design and manufacturing firm.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eSunTrust Equipment Finance \u0026amp; Leasing\u003c/strong\u003e\u0026nbsp;in connection with the Chapter 11 case of Dean Foods, America's larges milk producer.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eTD Bank\u003c/strong\u003e, as LC Issuer and Lender, in connection with the Chapter 11 bankruptcy case of Pacific Gas and Electric Company (N.D. Cal.), the nation's largest utility.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eIgnite Restaurant Group\u003c/strong\u003e\u0026nbsp;in the successful out of court sale of its Macaroni Grill casual dining business.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMedical Staffing Network Healthcare, LLC\u0026nbsp;\u003c/strong\u003ein the sale of its business.\u003c/p\u003e","\u003cp\u003eServed as Debtor\u0026rsquo;s counsel to\u0026nbsp;\u003cstrong\u003eMFM Industries, Inc.\u0026nbsp;\u003c/strong\u003ein its Chapter 11 bankruptcy case (D. Del.) and sale of its business.\u003c/p\u003e","\u003cp\u003eServed as Debtors\u0026rsquo; counsel to\u0026nbsp;\u003cstrong\u003eSea Island Company\u0026nbsp;\u003c/strong\u003eand its affiliates in their Chapter 11 bankruptcy cases (S.D. Ga.) and sale of their businesses.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eGE Capital\u003c/strong\u003e\u0026nbsp;as lender and debtor-in-possession lender in the Chapter 11 cases of Scovill Fasteners Inc. and its affiliates.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eGE Capital\u0026nbsp;\u003c/strong\u003eas lender in the Chapter 11 bankruptcy case of Black Crow Media Company in the restructuring of several radio stations in the Middle District of Florida\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":10,"guid":"10.capabilities","index":0,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":1,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":4,"source":"capabilities"},{"id":1261,"guid":"1261.smart_tags","index":5,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":6,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Dutson","nick_name":"Jeff","clerkships":[{"name":"Law Clerk, Hon. E. Grady Jolly, U.S. Court of Appeals for the Fifth Circuit","years_held":"2008-2009"}],"first_name":"Jeffrey","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"R.","name_suffix":"","recognitions":[{"title":"Elected as a Trustee of the American College of Investment Counsel","detail":"ACIC, 2024"},{"title":"Recognized as Up-and-Coming for Bankruptcy/Restructuring","detail":"CHAMBERS USA 2020 GUIDE"},{"title":"Rising Star: Financial Restructuring","detail":"IFLR 1000 US, 2018 and 2020"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJeff Dutson is a restructuring\u0026nbsp;partner in King \u0026amp; Spalding's Leveraged Finance \u0026amp; Restructuring practice group. Jeff\u0026nbsp;represents corporate debtors in Chapter 11 bankruptcy cases throughout the country as well as buyers and sellers in distressed M\u0026amp;A transactions. Jeff also represents\u0026nbsp;banks and other investors in connection with their most complex restructurings, bankruptcy, and finance\u0026nbsp;matters. Jeff\u0026rsquo;s practice spans a wide variety of industries, including the restaurant, real estate, healthcare, energy, transportation, manufacturing, and aviation\u0026nbsp;industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff has been\u0026nbsp;recognized for his work in Bankruptcy and Restructuring by \u003cem\u003eChambers USA \u003c/em\u003eeach year since 2020. In 2021, Jeff was recognized by the American Bankruptcy Institute as part of its 40 Under 40 list of emerging leaders in the insolvency industry. Jeff\u0026nbsp;currently serves as the Co-Chair for\u0026nbsp;the Advisory Board of the American Bankruptcy Institute Southeastern Workshop.\u0026nbsp;He\u0026nbsp;is a fellow of\u0026nbsp;the American College of Investment Counsel and serves on the Board of Trustees for the college.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eOriginally from Atlanta, Georgia, Jeff is a graduate of the\u0026nbsp;University of Chicago (where he earned his law degree, with honors) and the University of Georgia (where he earned his bachelor's degree, with honors).\u0026nbsp;Prior to joining the firm, Jeff served as a law clerk for the Honorable E. Grady Jolly of the U.S. Court of Appeals for the Fifth Circuit.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSelected Publications\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eUnitranche Credit Facilities and the LSTA New Form AAL\u003c/em\u003e, American Bankruptcy Institute Journal, May 2019, with Sarah R. Borders and Jeffrey Misher.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eFifth Circuit Denies Post-Petition Default Interest to Fully Secured Creditors\u003c/em\u003e, The Banking Law Journal, September 2019, with Sarah Primrose and Nadia Saleem.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eOrder's Up!: Navigating Complex Restaurant Restructurings\u003c/em\u003e, American Bankruptcy Institute Journal, July 2018, with Sarah R. Borders.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eWhen Cash Might Not be King: Acquiring Nonprofit Hospitals in Bankruptcy, \u003c/em\u003eAmerican Bankruptcy Institute Journal, September 2017, with Paul K. Ferdinands.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eGoing Once, Going Twice, Sold! (Maybe): Reopening Auctions\u003c/em\u003e, American Bankruptcy Institute Journal, February 2014, with W. Austin Jowers.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eSuccessor Liability under the FLSA: Buyers of Distressed Companies Beware\u003c/em\u003e, American Bankruptcy Institute Journal, June 2013, with Paul K. Ferdinands.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026ldquo;Unfinished Business\" after Geron and Coudert\u003c/em\u003e \u003cem\u003eBrothers\u003c/em\u003e, Dow Jones Daily Bankruptcy Review, September 11, 2012, with Mark M. Maloney.\u003c/p\u003e","matters":["\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eRed Lobster\u003c/strong\u003e\u0026nbsp;in its Chapter 11 bankruptcy proceedings in the Middle District of Florida.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eOn The Border\u003c/strong\u003e, a national restaurant chain, in its Chapter 11 bankruptcy proceedings.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eDCL Corporation\u003c/strong\u003e, a global pigments manufacturer, in its Chapter 11 bankruptcy proceedings in the District of Delaware and Canada.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eIgnite Restaurant Group, Inc.\u003c/strong\u003e, and its affiliate\u0026nbsp;\u003cstrong\u003eJoe's Crab Shack\u003c/strong\u003e, in their Chapter 11 bankruptcy proceedings in the Southern District of Texas.\u003c/p\u003e","\u003cp\u003eServed as Debtors' counsel to\u0026nbsp;\u003cstrong\u003eThe Krystal Company\u003c/strong\u003e, and its affiliates, in their Chapter 11 bankruptcy proceedings in the Northern District of Georgia.\u003c/p\u003e","\u003cp\u003eServed as Debtor\u0026rsquo;s counsel to\u0026nbsp;\u003cstrong\u003eAstroTurf, LLC\u003c/strong\u003e\u0026nbsp;in its Chapter 11 bankruptcy case and sale of its business.\u003c/p\u003e","\u003cp\u003eServed as Debtors\u0026rsquo; counsel to\u0026nbsp;\u003cstrong\u003eCagle\u0026rsquo;s, Inc.\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eCagle\u0026rsquo;s Farms, Inc.\u0026nbsp;\u003c/strong\u003ein their Chapter 11 bankruptcy cases and sale of their businesses. King \u0026amp; Spalding was recognized in connection with the Cagle\u0026rsquo;s transaction, which was named 2013 National Transaction of the Year (Large Company Category) by the international Turnaround Management Association.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eWells Fargo Bank, N.A.\u0026nbsp;\u003c/strong\u003eas Administrative Agent and Lender in the Chapter 11 bankruptcy case of Premier Kings, Inc., a large operator of Burger King franchises, in the Northern District of Alabama\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eGeorgia's Own Credit Union\u0026nbsp;\u003c/strong\u003eas Lender and DIP Lender in the Chapter 11 bankruptcy case of Ryze Renewables, LLC in the District of Delaware\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eTruist Bank\u003c/strong\u003e\u0026nbsp;(successor to SunTrust Bank) and\u0026nbsp;\u003cstrong\u003eSunTrust Equipment Finance \u0026amp; Leasing\u003c/strong\u003e\u0026nbsp;in\u0026nbsp;\u003cem\u003eSunTrust Equipment Finance \u0026amp; Leasing v. International Speedway Corporation\u003c/em\u003e\u0026nbsp;(M.D. Fla.).\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eThe Prudential Insurance Company of America\u003c/strong\u003e, as senior secured noteholder, in connection with the Chapter 11 bankruptcy case of The Legal Coverage Group (E.D. Penn.).\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCitizens Bank\u003c/strong\u003e, as secured lender, in connection with the pre-petition restructuring and Chapter 11 case of Schramm, Inc. (D. Del.), a manufacturer and supplier of branded land-based hydraulic drilling equipment.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eCitizens Bank\u003c/strong\u003e, as administrative agent for senior secured lenders, in out-of-court restructuring of large mechanical design and manufacturing firm.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eSunTrust Equipment Finance \u0026amp; Leasing\u003c/strong\u003e\u0026nbsp;in connection with the Chapter 11 case of Dean Foods, America's larges milk producer.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eTD Bank\u003c/strong\u003e, as LC Issuer and Lender, in connection with the Chapter 11 bankruptcy case of Pacific Gas and Electric Company (N.D. Cal.), the nation's largest utility.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eIgnite Restaurant Group\u003c/strong\u003e\u0026nbsp;in the successful out of court sale of its Macaroni Grill casual dining business.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMedical Staffing Network Healthcare, LLC\u0026nbsp;\u003c/strong\u003ein the sale of its business.\u003c/p\u003e","\u003cp\u003eServed as Debtor\u0026rsquo;s counsel to\u0026nbsp;\u003cstrong\u003eMFM Industries, Inc.\u0026nbsp;\u003c/strong\u003ein its Chapter 11 bankruptcy case (D. Del.) and sale of its business.\u003c/p\u003e","\u003cp\u003eServed as Debtors\u0026rsquo; counsel to\u0026nbsp;\u003cstrong\u003eSea Island Company\u0026nbsp;\u003c/strong\u003eand its affiliates in their Chapter 11 bankruptcy cases (S.D. Ga.) and sale of their businesses.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eGE Capital\u003c/strong\u003e\u0026nbsp;as lender and debtor-in-possession lender in the Chapter 11 cases of Scovill Fasteners Inc. and its affiliates.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eGE Capital\u0026nbsp;\u003c/strong\u003eas lender in the Chapter 11 bankruptcy case of Black Crow Media Company in the restructuring of several radio stations in the Middle District of Florida\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e"],"recognitions":[{"title":"Elected as a Trustee of the American College of Investment Counsel","detail":"ACIC, 2024"},{"title":"Recognized as Up-and-Coming for Bankruptcy/Restructuring","detail":"CHAMBERS USA 2020 GUIDE"},{"title":"Rising Star: Financial Restructuring","detail":"IFLR 1000 US, 2018 and 2020"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":834}]},"capability_group_id":1},"created_at":"2026-01-26T21:11:34.000Z","updated_at":"2026-01-26T21:11:34.000Z","searchable_text":"Dutson{{ FIELD }}{:title=\u0026gt;\"Elected as a Trustee of the American College of Investment Counsel\", :detail=\u0026gt;\"ACIC, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as Up-and-Coming for Bankruptcy/Restructuring\", :detail=\u0026gt;\"CHAMBERS USA 2020 GUIDE\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star: Financial Restructuring\", :detail=\u0026gt;\"IFLR 1000 US, 2018 and 2020\"}{{ FIELD }}Served as Debtors' counsel to Red Lobster in its Chapter 11 bankruptcy proceedings in the Middle District of Florida.{{ FIELD }}Served as Debtors' counsel to On The Border, a national restaurant chain, in its Chapter 11 bankruptcy proceedings.{{ FIELD }}Served as Debtors' counsel to DCL Corporation, a global pigments manufacturer, in its Chapter 11 bankruptcy proceedings in the District of Delaware and Canada.{{ FIELD }}Served as Debtors' counsel to Ignite Restaurant Group, Inc., and its affiliate Joe's Crab Shack, in their Chapter 11 bankruptcy proceedings in the Southern District of Texas.{{ FIELD }}Served as Debtors' counsel to The Krystal Company, and its affiliates, in their Chapter 11 bankruptcy proceedings in the Northern District of Georgia.{{ FIELD }}Served as Debtor’s counsel to AstroTurf, LLC in its Chapter 11 bankruptcy case and sale of its business.{{ FIELD }}Served as Debtors’ counsel to Cagle’s, Inc. and Cagle’s Farms, Inc. in their Chapter 11 bankruptcy cases and sale of their businesses. King \u0026amp; Spalding was recognized in connection with the Cagle’s transaction, which was named 2013 National Transaction of the Year (Large Company Category) by the international Turnaround Management Association.{{ FIELD }}Represented Wells Fargo Bank, N.A. as Administrative Agent and Lender in the Chapter 11 bankruptcy case of Premier Kings, Inc., a large operator of Burger King franchises, in the Northern District of Alabama.{{ FIELD }}Represented Georgia's Own Credit Union as Lender and DIP Lender in the Chapter 11 bankruptcy case of Ryze Renewables, LLC in the District of Delaware.{{ FIELD }}Representing Truist Bank (successor to SunTrust Bank) and SunTrust Equipment Finance \u0026amp; Leasing in SunTrust Equipment Finance \u0026amp; Leasing v. International Speedway Corporation (M.D. Fla.).{{ FIELD }}Represented The Prudential Insurance Company of America, as senior secured noteholder, in connection with the Chapter 11 bankruptcy case of The Legal Coverage Group (E.D. Penn.).{{ FIELD }}Represented Citizens Bank, as secured lender, in connection with the pre-petition restructuring and Chapter 11 case of Schramm, Inc. (D. Del.), a manufacturer and supplier of branded land-based hydraulic drilling equipment.{{ FIELD }}Represented Citizens Bank, as administrative agent for senior secured lenders, in out-of-court restructuring of large mechanical design and manufacturing firm.{{ FIELD }}Representing SunTrust Equipment Finance \u0026amp; Leasing in connection with the Chapter 11 case of Dean Foods, America's larges milk producer.{{ FIELD }}Represented TD Bank, as LC Issuer and Lender, in connection with the Chapter 11 bankruptcy case of Pacific Gas and Electric Company (N.D. Cal.), the nation's largest utility.{{ FIELD }}Represented Ignite Restaurant Group in the successful out of court sale of its Macaroni Grill casual dining business.{{ FIELD }}Represented Medical Staffing Network Healthcare, LLC in the sale of its business.{{ FIELD }}Served as Debtor’s counsel to MFM Industries, Inc. in its Chapter 11 bankruptcy case (D. Del.) and sale of its business.{{ FIELD }}Served as Debtors’ counsel to Sea Island Company and its affiliates in their Chapter 11 bankruptcy cases (S.D. Ga.) and sale of their businesses.{{ FIELD }}Represented GE Capital as lender and debtor-in-possession lender in the Chapter 11 cases of Scovill Fasteners Inc. and its affiliates.{{ FIELD }}Represented GE Capital as lender in the Chapter 11 bankruptcy case of Black Crow Media Company in the restructuring of several radio stations in the Middle District of Florida.{{ FIELD }}Jeff Dutson is a restructuring partner in King \u0026amp; Spalding's Leveraged Finance \u0026amp; Restructuring practice group. Jeff represents corporate debtors in Chapter 11 bankruptcy cases throughout the country as well as buyers and sellers in distressed M\u0026amp;A transactions. Jeff also represents banks and other investors in connection with their most complex restructurings, bankruptcy, and finance matters. Jeff’s practice spans a wide variety of industries, including the restaurant, real estate, healthcare, energy, transportation, manufacturing, and aviation industries.\nJeff has been recognized for his work in Bankruptcy and Restructuring by Chambers USA each year since 2020. In 2021, Jeff was recognized by the American Bankruptcy Institute as part of its 40 Under 40 list of emerging leaders in the insolvency industry. Jeff currently serves as the Co-Chair for the Advisory Board of the American Bankruptcy Institute Southeastern Workshop. He is a fellow of the American College of Investment Counsel and serves on the Board of Trustees for the college. \nOriginally from Atlanta, Georgia, Jeff is a graduate of the University of Chicago (where he earned his law degree, with honors) and the University of Georgia (where he earned his bachelor's degree, with honors). Prior to joining the firm, Jeff served as a law clerk for the Honorable E. Grady Jolly of the U.S. Court of Appeals for the Fifth Circuit.\nSelected Publications\nUnitranche Credit Facilities and the LSTA New Form AAL, American Bankruptcy Institute Journal, May 2019, with Sarah R. Borders and Jeffrey Misher.\nFifth Circuit Denies Post-Petition Default Interest to Fully Secured Creditors, The Banking Law Journal, September 2019, with Sarah Primrose and Nadia Saleem.\nOrder's Up!: Navigating Complex Restaurant Restructurings, American Bankruptcy Institute Journal, July 2018, with Sarah R. Borders.\nWhen Cash Might Not be King: Acquiring Nonprofit Hospitals in Bankruptcy, American Bankruptcy Institute Journal, September 2017, with Paul K. Ferdinands.\nGoing Once, Going Twice, Sold! (Maybe): Reopening Auctions, American Bankruptcy Institute Journal, February 2014, with W. Austin Jowers.\nSuccessor Liability under the FLSA: Buyers of Distressed Companies Beware, American Bankruptcy Institute Journal, June 2013, with Paul K. Ferdinands.\n“Unfinished Business\" after Geron and Coudert Brothers, Dow Jones Daily Bankruptcy Review, September 11, 2012, with Mark M. Maloney. Partner Elected as a Trustee of the American College of Investment Counsel ACIC, 2024 Recognized as Up-and-Coming for Bankruptcy/Restructuring CHAMBERS USA 2020 GUIDE Rising Star: Financial Restructuring IFLR 1000 US, 2018 and 2020 University of Georgia University of Georgia School of Law University of Chicago University of Chicago Law School U.S. District Court for the Northern District of Georgia Georgia Law Clerk, Hon. E. Grady Jolly, U.S. Court of Appeals for the Fifth Circuit Served as Debtors' counsel to Red Lobster in its Chapter 11 bankruptcy proceedings in the Middle District of Florida. Served as Debtors' counsel to On The Border, a national restaurant chain, in its Chapter 11 bankruptcy proceedings. Served as Debtors' counsel to DCL Corporation, a global pigments manufacturer, in its Chapter 11 bankruptcy proceedings in the District of Delaware and Canada. Served as Debtors' counsel to Ignite Restaurant Group, Inc., and its affiliate Joe's Crab Shack, in their Chapter 11 bankruptcy proceedings in the Southern District of Texas. Served as Debtors' counsel to The Krystal Company, and its affiliates, in their Chapter 11 bankruptcy proceedings in the Northern District of Georgia. Served as Debtor’s counsel to AstroTurf, LLC in its Chapter 11 bankruptcy case and sale of its business. Served as Debtors’ counsel to Cagle’s, Inc. and Cagle’s Farms, Inc. in their Chapter 11 bankruptcy cases and sale of their businesses. King \u0026amp; Spalding was recognized in connection with the Cagle’s transaction, which was named 2013 National Transaction of the Year (Large Company Category) by the international Turnaround Management Association. Represented Wells Fargo Bank, N.A. as Administrative Agent and Lender in the Chapter 11 bankruptcy case of Premier Kings, Inc., a large operator of Burger King franchises, in the Northern District of Alabama. Represented Georgia's Own Credit Union as Lender and DIP Lender in the Chapter 11 bankruptcy case of Ryze Renewables, LLC in the District of Delaware. Representing Truist Bank (successor to SunTrust Bank) and SunTrust Equipment Finance \u0026amp; Leasing in SunTrust Equipment Finance \u0026amp; Leasing v. International Speedway Corporation (M.D. Fla.). Represented The Prudential Insurance Company of America, as senior secured noteholder, in connection with the Chapter 11 bankruptcy case of The Legal Coverage Group (E.D. Penn.). Represented Citizens Bank, as secured lender, in connection with the pre-petition restructuring and Chapter 11 case of Schramm, Inc. (D. Del.), a manufacturer and supplier of branded land-based hydraulic drilling equipment. Represented Citizens Bank, as administrative agent for senior secured lenders, in out-of-court restructuring of large mechanical design and manufacturing firm. Representing SunTrust Equipment Finance \u0026amp; Leasing in connection with the Chapter 11 case of Dean Foods, America's larges milk producer. Represented TD Bank, as LC Issuer and Lender, in connection with the Chapter 11 bankruptcy case of Pacific Gas and Electric Company (N.D. Cal.), the nation's largest utility. Represented Ignite Restaurant Group in the successful out of court sale of its Macaroni Grill casual dining business. Represented Medical Staffing Network Healthcare, LLC in the sale of its business. Served as Debtor’s counsel to MFM Industries, Inc. in its Chapter 11 bankruptcy case (D. Del.) and sale of its business. Served as Debtors’ counsel to Sea Island Company and its affiliates in their Chapter 11 bankruptcy cases (S.D. Ga.) and sale of their businesses. Represented GE Capital as lender and debtor-in-possession lender in the Chapter 11 cases of Scovill Fasteners Inc. and its affiliates. Represented GE Capital as lender in the Chapter 11 bankruptcy case of Black Crow Media Company in the restructuring of several radio stations in the Middle District of Florida.","searchable_name":"Jeffrey R. Dutson (Jeff)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":431883,"version":1,"owner_type":"Person","owner_id":3969,"payload":{"bio":"\u003cp\u003eA partner in our FDA and Life Sciences practice, Lisa has almost 25\u0026nbsp;years of experience developing regulatory, legislative and litigation solutions for companies selling FDA-regulated products (i.e., drugs, devices, biologics, cosmetics, and tobacco). \u0026nbsp;She has served as an advisor to high-level public officials and C-suite executives on complex regulatory, policy, and litigation issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Lisa served as a Senior Policy Advisor in the FDA Commissioner\u0026rsquo;s Office and as the Deputy Chief of Staff to the Commissioner of Food and Drugs. In these roles, she provided strategic counsel on the agency\u0026rsquo;s most significant and complex issues. These included off-label marketing, mobile medical apps/digital health, opioid misuse and abuse, in vitro diagnostics and next generation sequencing, cosmetic legislation and regulation, and antimicrobial drug development and use. During her tenure at the FDA, she also worked closely with Congress, the Department of Health and Human Services, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) and the Drug Enforcement Administration (DEA).\u003c/p\u003e\n\u003cp\u003eLisa is a frequent author and speaker on topics including:\u0026nbsp; digital health, advertising and promoting drugs and devices, remedying unfair competition in the drug and device space, women\u0026rsquo;s health issues, admissibility of 510(k)s in product liability lawsuits, preemption, in vitro diagnostics, the 21st Century Cures Act, and other topics. Lisa is Chambers ranked for Pharmaceutical/Medical Products Law. She also has been repeatedly recognized by Legal 500 as a Next Generation Partner and as a Recommended Key Lawyer for FDA Regulatory Law (2017, 2019, 2020, 2021, 2022, 2023, 2024) and for Government Relations (2016). Legal 500 has distinguished her for her expertise in digital health/AI and in pre-market strategies, and praised for her \u0026ldquo;unending enthusiasm to take on client\u0026rsquo;s causes as her own.\"\u003c/p\u003e","slug":"lisa-dwyer","email":"ldwyer@kslaw.com","phone":null,"matters":["\u003cp\u003eFocus on Digital Health/Telehealth\u003c/p\u003e","\u003cp\u003eFocus on In Vitro Diagnostic Tests and Laboratory Developed Tests\u003c/p\u003e","\u003cp\u003eFDA/FTC regulation of advertising and promotion\u003c/p\u003e","\u003cp\u003ePre-market development (drugs and devices (including digital health products))\u003c/p\u003e","\u003cp\u003eFDA product submissions (drugs and devices (including digital health products))\u003c/p\u003e","\u003cp\u003eDevelops regulatory, legislative and litigation solutions for unfair competition in the drug/device space\u003c/p\u003e\n\u003cp\u003e- Lanham Act\u003c/p\u003e\n\u003cp\u003e- Unfair trade practice statutes (state and federal)\u003c/p\u003e","\u003cp\u003eEngages FDA and Congress on key issues related to FDA-regulated products\u003c/p\u003e","\u003cp\u003eResponds to FDA/FTC inquires, FDA warning letters, and FDA 483s\u003c/p\u003e","\u003cp\u003eExperience remedying cGMP issues at facilities making OTC and Rx drugs and cosmetics\u003c/p\u003e","\u003cp\u003eCo-Chairs Women's Health Initiative\u003c/p\u003e","\u003cp\u003eMember of Cannabis Steering Committee\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":53}]},"expertise":[{"id":2,"guid":"2.capabilities","index":0,"source":"capabilities"},{"id":3,"guid":"3.smart_tags","index":1,"source":"smartTags"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":5,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":6,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":7,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":8,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":9,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":10,"source":"smartTags"},{"id":1206,"guid":"1206.smart_tags","index":11,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":12,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":13,"source":"capabilities"}],"is_active":true,"last_name":"Dwyer","nick_name":"Lisa","clerkships":[],"first_name":"Lisa","title_rank":9999,"updated_by":202,"law_schools":[{"id":753,"meta":{"degree":"J.D.","honors":"honors","is_law_school":"1","graduation_date":"1998-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Next Generation Lawyer","detail":"Legal 500, 2017 and 2019"},{"title":"Recognition for Government Relations ","detail":"Legal 500, 2016"},{"title":"FDA Commissioner’s Special Citation, Issuance of the Draft Guidance for Laboratory Developed Tests ","detail":"FDA Award Ceremony, 2015"},{"title":"FDA Group Recognition Award, Publishing FDA Strategic Priorities 2014–2018 Document","detail":"FDA Award Ceremony, 2015"},{"title":"FDA Commissioner’s Special Citation, Issuance of the Unique Device Identification (UDI) System Final Rule ","detail":"FDA Award Ceremony, 2014"},{"title":"FDA Group Recognition Award, FDA Language Access Plan Working Group","detail":"FDA Award Ceremony, 2014"},{"title":"FDA Group Recognition Award, Good Guidance Practices-Best Practices Working Group (Group Leader)","detail":"FDA Award Ceremony, 2012"},{"title":"FDA Group Recognition Award, Menu Labeling Working Group","detail":"CFSAN/FDA Award Ceremony, 2011"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eA partner in our FDA and Life Sciences practice, Lisa has almost 25\u0026nbsp;years of experience developing regulatory, legislative and litigation solutions for companies selling FDA-regulated products (i.e., drugs, devices, biologics, cosmetics, and tobacco). \u0026nbsp;She has served as an advisor to high-level public officials and C-suite executives on complex regulatory, policy, and litigation issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Lisa served as a Senior Policy Advisor in the FDA Commissioner\u0026rsquo;s Office and as the Deputy Chief of Staff to the Commissioner of Food and Drugs. In these roles, she provided strategic counsel on the agency\u0026rsquo;s most significant and complex issues. These included off-label marketing, mobile medical apps/digital health, opioid misuse and abuse, in vitro diagnostics and next generation sequencing, cosmetic legislation and regulation, and antimicrobial drug development and use. During her tenure at the FDA, she also worked closely with Congress, the Department of Health and Human Services, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) and the Drug Enforcement Administration (DEA).\u003c/p\u003e\n\u003cp\u003eLisa is a frequent author and speaker on topics including:\u0026nbsp; digital health, advertising and promoting drugs and devices, remedying unfair competition in the drug and device space, women\u0026rsquo;s health issues, admissibility of 510(k)s in product liability lawsuits, preemption, in vitro diagnostics, the 21st Century Cures Act, and other topics. Lisa is Chambers ranked for Pharmaceutical/Medical Products Law. She also has been repeatedly recognized by Legal 500 as a Next Generation Partner and as a Recommended Key Lawyer for FDA Regulatory Law (2017, 2019, 2020, 2021, 2022, 2023, 2024) and for Government Relations (2016). Legal 500 has distinguished her for her expertise in digital health/AI and in pre-market strategies, and praised for her \u0026ldquo;unending enthusiasm to take on client\u0026rsquo;s causes as her own.\"\u003c/p\u003e","matters":["\u003cp\u003eFocus on Digital Health/Telehealth\u003c/p\u003e","\u003cp\u003eFocus on In Vitro Diagnostic Tests and Laboratory Developed Tests\u003c/p\u003e","\u003cp\u003eFDA/FTC regulation of advertising and promotion\u003c/p\u003e","\u003cp\u003ePre-market development (drugs and devices (including digital health products))\u003c/p\u003e","\u003cp\u003eFDA product submissions (drugs and devices (including digital health products))\u003c/p\u003e","\u003cp\u003eDevelops regulatory, legislative and litigation solutions for unfair competition in the drug/device space\u003c/p\u003e\n\u003cp\u003e- Lanham Act\u003c/p\u003e\n\u003cp\u003e- Unfair trade practice statutes (state and federal)\u003c/p\u003e","\u003cp\u003eEngages FDA and Congress on key issues related to FDA-regulated products\u003c/p\u003e","\u003cp\u003eResponds to FDA/FTC inquires, FDA warning letters, and FDA 483s\u003c/p\u003e","\u003cp\u003eExperience remedying cGMP issues at facilities making OTC and Rx drugs and cosmetics\u003c/p\u003e","\u003cp\u003eCo-Chairs Women's Health Initiative\u003c/p\u003e","\u003cp\u003eMember of Cannabis Steering Committee\u003c/p\u003e"],"recognitions":[{"title":"Next Generation Lawyer","detail":"Legal 500, 2017 and 2019"},{"title":"Recognition for Government Relations ","detail":"Legal 500, 2016"},{"title":"FDA Commissioner’s Special Citation, Issuance of the Draft Guidance for Laboratory Developed Tests ","detail":"FDA Award Ceremony, 2015"},{"title":"FDA Group Recognition Award, Publishing FDA Strategic Priorities 2014–2018 Document","detail":"FDA Award Ceremony, 2015"},{"title":"FDA Commissioner’s Special Citation, Issuance of the Unique Device Identification (UDI) System Final Rule ","detail":"FDA Award Ceremony, 2014"},{"title":"FDA Group Recognition Award, FDA Language Access Plan Working Group","detail":"FDA Award Ceremony, 2014"},{"title":"FDA Group Recognition Award, Good Guidance Practices-Best Practices Working Group (Group Leader)","detail":"FDA Award Ceremony, 2012"},{"title":"FDA Group Recognition Award, Menu Labeling Working Group","detail":"CFSAN/FDA Award Ceremony, 2011"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11487}]},"capability_group_id":2},"created_at":"2025-07-09T20:54:25.000Z","updated_at":"2025-07-09T20:54:25.000Z","searchable_text":"Dwyer{{ FIELD }}{:title=\u0026gt;\"Next Generation Lawyer\", :detail=\u0026gt;\"Legal 500, 2017 and 2019\"}{{ FIELD }}{:title=\u0026gt;\"Recognition for Government Relations \", :detail=\u0026gt;\"Legal 500, 2016\"}{{ FIELD }}{:title=\u0026gt;\"FDA Commissioner’s Special Citation, Issuance of the Draft Guidance for Laboratory Developed Tests \", :detail=\u0026gt;\"FDA Award Ceremony, 2015\"}{{ FIELD }}{:title=\u0026gt;\"FDA Group Recognition Award, Publishing FDA Strategic Priorities 2014–2018 Document\", :detail=\u0026gt;\"FDA Award Ceremony, 2015\"}{{ FIELD }}{:title=\u0026gt;\"FDA Commissioner’s Special Citation, Issuance of the Unique Device Identification (UDI) System Final Rule \", :detail=\u0026gt;\"FDA Award Ceremony, 2014\"}{{ FIELD }}{:title=\u0026gt;\"FDA Group Recognition Award, FDA Language Access Plan Working Group\", :detail=\u0026gt;\"FDA Award Ceremony, 2014\"}{{ FIELD }}{:title=\u0026gt;\"FDA Group Recognition Award, Good Guidance Practices-Best Practices Working Group (Group Leader)\", :detail=\u0026gt;\"FDA Award Ceremony, 2012\"}{{ FIELD }}{:title=\u0026gt;\"FDA Group Recognition Award, Menu Labeling Working Group\", :detail=\u0026gt;\"CFSAN/FDA Award Ceremony, 2011\"}{{ FIELD }}Focus on Digital Health/Telehealth{{ FIELD }}Focus on In Vitro Diagnostic Tests and Laboratory Developed Tests{{ FIELD }}FDA/FTC regulation of advertising and promotion{{ FIELD }}Pre-market development (drugs and devices (including digital health products)){{ FIELD }}FDA product submissions (drugs and devices (including digital health products)){{ FIELD }}Develops regulatory, legislative and litigation solutions for unfair competition in the drug/device space\n- Lanham Act\n- Unfair trade practice statutes (state and federal){{ FIELD }}Engages FDA and Congress on key issues related to FDA-regulated products{{ FIELD }}Responds to FDA/FTC inquires, FDA warning letters, and FDA 483s{{ FIELD }}Experience remedying cGMP issues at facilities making OTC and Rx drugs and cosmetics{{ FIELD }}Co-Chairs Women's Health Initiative{{ FIELD }}Member of Cannabis Steering Committee{{ FIELD }}A partner in our FDA and Life Sciences practice, Lisa has almost 25 years of experience developing regulatory, legislative and litigation solutions for companies selling FDA-regulated products (i.e., drugs, devices, biologics, cosmetics, and tobacco).  She has served as an advisor to high-level public officials and C-suite executives on complex regulatory, policy, and litigation issues.\nPreviously, Lisa served as a Senior Policy Advisor in the FDA Commissioner’s Office and as the Deputy Chief of Staff to the Commissioner of Food and Drugs. In these roles, she provided strategic counsel on the agency’s most significant and complex issues. These included off-label marketing, mobile medical apps/digital health, opioid misuse and abuse, in vitro diagnostics and next generation sequencing, cosmetic legislation and regulation, and antimicrobial drug development and use. During her tenure at the FDA, she also worked closely with Congress, the Department of Health and Human Services, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) and the Drug Enforcement Administration (DEA).\nLisa is a frequent author and speaker on topics including:  digital health, advertising and promoting drugs and devices, remedying unfair competition in the drug and device space, women’s health issues, admissibility of 510(k)s in product liability lawsuits, preemption, in vitro diagnostics, the 21st Century Cures Act, and other topics. Lisa is Chambers ranked for Pharmaceutical/Medical Products Law. She also has been repeatedly recognized by Legal 500 as a Next Generation Partner and as a Recommended Key Lawyer for FDA Regulatory Law (2017, 2019, 2020, 2021, 2022, 2023, 2024) and for Government Relations (2016). Legal 500 has distinguished her for her expertise in digital health/AI and in pre-market strategies, and praised for her “unending enthusiasm to take on client’s causes as her own.\" Lisa M Dwyer Partner Next Generation Lawyer Legal 500, 2017 and 2019 Recognition for Government Relations  Legal 500, 2016 FDA Commissioner’s Special Citation, Issuance of the Draft Guidance for Laboratory Developed Tests  FDA Award Ceremony, 2015 FDA Group Recognition Award, Publishing FDA Strategic Priorities 2014–2018 Document FDA Award Ceremony, 2015 FDA Commissioner’s Special Citation, Issuance of the Unique Device Identification (UDI) System Final Rule  FDA Award Ceremony, 2014 FDA Group Recognition Award, FDA Language Access Plan Working Group FDA Award Ceremony, 2014 FDA Group Recognition Award, Good Guidance Practices-Best Practices Working Group (Group Leader) FDA Award Ceremony, 2012 FDA Group Recognition Award, Menu Labeling Working Group CFSAN/FDA Award Ceremony, 2011 Wesleyan University  George Washington University George Washington University Law School District of Columbia Massachusetts Pennsylvania Focus on Digital Health/Telehealth Focus on In Vitro Diagnostic Tests and Laboratory Developed Tests FDA/FTC regulation of advertising and promotion Pre-market development (drugs and devices (including digital health products)) FDA product submissions (drugs and devices (including digital health products)) Develops regulatory, legislative and litigation solutions for unfair competition in the drug/device space\n- Lanham Act\n- Unfair trade practice statutes (state and federal) Engages FDA and Congress on key issues related to FDA-regulated products Responds to FDA/FTC inquires, FDA warning letters, and FDA 483s Experience remedying cGMP issues at facilities making OTC and Rx drugs and cosmetics Co-Chairs Women's Health Initiative Member of Cannabis Steering Committee","searchable_name":"Lisa M. Dwyer","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}